<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Neurosci.</journal-id>
<journal-title>Frontiers in Cellular Neuroscience</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Neurosci.</abbrev-journal-title>
<issn pub-type="epub">1662-5102</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fncel.2023.1253543</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cellular Neuroscience</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Neuronal models of TDP-43 proteinopathy display reduced axonal translation, increased oxidative stress, and defective exocytosis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Pisciottani</surname>
<given-names>Alessandra</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2369480/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Croci</surname>
<given-names>Laura</given-names>
</name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2369534/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lauria</surname>
<given-names>Fabio</given-names>
</name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Marullo</surname>
<given-names>Chiara</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2545322/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Savino</surname>
<given-names>Elisa</given-names>
</name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ambrosi</surname>
<given-names>Alessandro</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/99183/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Podini</surname>
<given-names>Paola</given-names>
</name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/68485/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Marchioretto</surname>
<given-names>Marta</given-names>
</name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2370369/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Casoni</surname>
<given-names>Filippo</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1132630/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cremona</surname>
<given-names>Ottavio</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Taverna</surname>
<given-names>Stefano</given-names>
</name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/33706/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Quattrini</surname>
<given-names>Angelo</given-names>
</name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/65742/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cioni</surname>
<given-names>Jean-Michel</given-names>
</name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1014608/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Viero</surname>
<given-names>Gabriella</given-names>
</name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Codazzi</surname>
<given-names>Franca</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/240880/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Consalez</surname>
<given-names>G. Giacomo</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2532007/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Faculty of Medicine and Surgery, Universit&#x00E0; Vita-Salute San Raffaele</institution>, <addr-line>Milan</addr-line>, <country>Italy</country></aff>
<aff id="aff2"><sup>2</sup><institution>Division of Neuroscience, IRCCS San Raffaele Scientific Institute</institution>, <addr-line>Milan</addr-line>, <country>Italy</country></aff>
<aff id="aff3"><sup>3</sup><institution>Institute of Biophysics, CNR Unit at Trento</institution>, <addr-line>Povo</addr-line>, <country>Italy</country></aff>
<author-notes>
<fn fn-type="edited-by" id="fn0001"><p>Edited by: Bradley J. Turner, University of Melbourne, Australia</p></fn>
<fn fn-type="edited-by" id="fn0002"><p>Reviewed by: Adrian Rodriguez-Contreras, Northwestern University, United States; Alberto Catanese, University of Ulm, Germany</p></fn>
<corresp id="c001">&#x002A;Correspondence: Franca Codazzi, <email>codazzi.franca@hsr.it</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>13</day>
<month>11</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>17</volume>
<elocation-id>1253543</elocation-id>
<history>
<date date-type="received">
<day>05</day>
<month>07</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>13</day>
<month>10</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2023 Pisciottani, Croci, Lauria, Marullo, Savino, Ambrosi, Podini, Marchioretto, Casoni, Cremona, Taverna, Quattrini, Cioni, Viero, Codazzi and Consalez.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Pisciottani, Croci, Lauria, Marullo, Savino, Ambrosi, Podini, Marchioretto, Casoni, Cremona, Taverna, Quattrini, Cioni, Viero, Codazzi and Consalez</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Amyotrophic lateral sclerosis (ALS) is a progressive, lethal neurodegenerative disease mostly affecting people around 50&#x2013;60&#x2009;years of age. TDP-43, an RNA-binding protein involved in pre-mRNA splicing and controlling mRNA stability and translation, forms neuronal cytoplasmic inclusions in an overwhelming majority of ALS patients, a phenomenon referred to as TDP-43 proteinopathy. These cytoplasmic aggregates disrupt mRNA transport and localization. The axon, like dendrites, is a site of mRNA translation, permitting the local synthesis of selected proteins. This is especially relevant in upper and lower motor neurons, whose axon spans long distances, likely accentuating their susceptibility to ALS-related noxae. In this work we have generated and characterized two cellular models, consisting of virtually pure populations of primary mouse cortical neurons expressing a human TDP-43 fusion protein, wt or carrying an ALS mutation. Both forms facilitate cytoplasmic aggregate formation, unlike the corresponding native proteins, giving rise to <italic>bona fide</italic> primary culture models of TDP-43 proteinopathy. Neurons expressing TDP-43 fusion proteins exhibit a global impairment in axonal protein synthesis, an increase in oxidative stress, and defects in presynaptic function and electrical activity. These changes correlate with deregulation of axonal levels of polysome-engaged mRNAs playing relevant roles in the same processes. Our data support the emerging notion that deregulation of mRNA metabolism and of axonal mRNA transport may trigger the dying-back neuropathy that initiates motor neuron degeneration in ALS.</p>
</abstract>
<kwd-group>
<kwd>amyotrophic lateral sclerosis</kwd>
<kwd>TDP-43 proteinopathy</kwd>
<kwd>cortical neurons</kwd>
<kwd>axonal translation</kwd>
<kwd>oxidative stress</kwd>
<kwd>synaptic function</kwd>
<kwd>calcium</kwd>
<kwd>polysome profiling</kwd>
</kwd-group>
<counts>
<fig-count count="5"/>
<table-count count="2"/>
<equation-count count="0"/>
<ref-count count="124"/>
<page-count count="18"/>
<word-count count="14579"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Cellular Neuropathology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="sec1">
<title>Introduction</title>
<p>Amyotrophic lateral sclerosis (ALS) is a progressive, lethal neurodegenerative disease affecting people around 50&#x2013;60&#x2009;years of age. The most common clinical signs are muscular weakness, spasticity, fasciculations and dysphagia, culminating in progressive paralysis and death (reviewed in <xref ref-type="bibr" rid="ref21">Brown and Al-Chalabi, 2017</xref>; <xref ref-type="bibr" rid="ref57">Hardiman et al., 2017</xref>). The most frequent cause of death is respiratory failure (reviewed in <xref ref-type="bibr" rid="ref51">Gil et al., 2008</xref>; <xref ref-type="bibr" rid="ref94">Niedermeyer et al., 2019</xref>). About 10% of ALS patients also show cognitive impairment consistent with fronto-temporal dementia (FTD), which is characterized by degeneration of neurons of the frontal and temporal lobes. More broadly, up to 50% of patients develop cognitive and/or behavioral impairments during disease progression (reviewed in <xref ref-type="bibr" rid="ref21">Brown and Al-Chalabi, 2017</xref>). Ten percent of ALS cases show familial inheritance, while the majority of patients have no family history and are classified as sporadic cases (reviewed in <xref ref-type="bibr" rid="ref57">Hardiman et al., 2017</xref>). ALS neuropathology is characterized by the degeneration of upper (cortical) and lower (cranial and spinal) motor neurons.</p>
<p>Since 1994, many ALS causative genes and risk factors have been discovered, including a number of genes primarily involved in RNA metabolism. The involvement of RNA-binding proteins (RBPs; <xref ref-type="bibr" rid="ref111">Sreedharan et al., 2008</xref>; <xref ref-type="bibr" rid="ref18">Blair et al., 2010</xref>) highlights the importance of altered RNA processing in ALS. TDP-43, a ubiquitously expressed RBP, has several functions: pre-mRNA splicing (<xref ref-type="bibr" rid="ref24">Buratti et al., 2001</xref>; <xref ref-type="bibr" rid="ref99">Polymenidou et al., 2011</xref>; <xref ref-type="bibr" rid="ref116">Tollervey et al., 2011</xref>; <xref ref-type="bibr" rid="ref48">Fratta et al., 2018</xref>; <xref ref-type="bibr" rid="ref120">Watanabe et al., 2020</xref>; <xref ref-type="bibr" rid="ref22">Brown et al., 2022</xref>), mRNA stability (<xref ref-type="bibr" rid="ref113">Strong et al., 2007</xref>; <xref ref-type="bibr" rid="ref29">Colombrita et al., 2012</xref>; <xref ref-type="bibr" rid="ref33">Costessi et al., 2014</xref>), including that of its own transcript (<xref ref-type="bibr" rid="ref8">Ayala et al., 2011</xref>), mRNA transport (<xref ref-type="bibr" rid="ref1">Alami et al., 2014</xref>; <xref ref-type="bibr" rid="ref88">Nagano et al., 2020</xref>), and the control of mRNA translation (<xref ref-type="bibr" rid="ref25">Chu et al., 2019</xref>; <xref ref-type="bibr" rid="ref20">Briese et al., 2020</xref>; Lauria and Maniscalco, under revision). TDP-43 is encoded by <italic>TARDBP</italic>, whose mutations account for about 5%&#x2013;10% of all forms of familial ALS (<xref ref-type="bibr" rid="ref111">Sreedharan et al., 2008</xref>; <xref ref-type="bibr" rid="ref68">Kraemer et al., 2010</xref>). However, while <italic>TARDBP</italic> mutations are relatively infrequent in ALS patients, TDP-43 is the main component of neuronal cytoplasmic inclusions found in 97% of all ALS patients, of both sporadic and familial origin. This phenomenon is referred to as TDP-43 proteinopathy (<xref ref-type="bibr" rid="ref6">Arai et al., 2006</xref>; <xref ref-type="bibr" rid="ref93">Neumann et al., 2006</xref>). TDP-43, a predominantly nuclear protein (reviewed in <xref ref-type="bibr" rid="ref28">Cohen et al., 2011</xref>), binds UG-rich regions of RNA targets (<xref ref-type="bibr" rid="ref24">Buratti et al., 2001</xref>; <xref ref-type="bibr" rid="ref9">Ayala et al., 2005</xref>), then shuttles to the cytoplasm (<xref ref-type="bibr" rid="ref10">Ayala et al., 2008</xref>). Its C-terminal domain contains an intrinsically disordered protein region, the low complexity domain, which promotes liquid&#x2013;liquid phase separation (LLPS) and liquid droplet formation, leading to the assembly of RNA granules (reviewed in <xref ref-type="bibr" rid="ref58">Harrison and Shorter, 2017</xref>; <xref ref-type="bibr" rid="ref123">Wolozin and Ivanov, 2019</xref>). Interestingly, the majority of ALS-mutations, located in the C-terminal domain (reviewed in <xref ref-type="bibr" rid="ref23">Buratti, 2015</xref>; <xref ref-type="bibr" rid="ref100">Prasad et al., 2019</xref>), modulate the ability of TDP-43 to induce LLPS (<xref ref-type="bibr" rid="ref31">Conicella et al., 2016</xref>) and may promote cytoplasmic aggregate formation, disrupting the subcellular transport and localization of its target mRNAs. While many proteins are synthesized in the neuronal soma and transported into the axon by fast or slow axonal transport (reviewed in <xref ref-type="bibr" rid="ref55">Guo et al., 2020</xref>), the axon, like dendrites, is a site of local mRNA translation (reviewed in <xref ref-type="bibr" rid="ref64">Jung et al., 2012</xref>; <xref ref-type="bibr" rid="ref82">Martinez et al., 2019</xref>; <xref ref-type="bibr" rid="ref107">Shigeoka et al., 2019</xref>; <xref ref-type="bibr" rid="ref49">Fusco et al., 2021</xref>). Messenger RNAs are transported along the axon to synthesize selected proteins locally through the translation machinery, whose composition undergoes remodeling <italic>in situ</italic> (<xref ref-type="bibr" rid="ref107">Shigeoka et al., 2019</xref>; <xref ref-type="bibr" rid="ref49">Fusco et al., 2021</xref>). Local translation occurs both constitutively and in response to stimuli acting far away from the cell body, in the axon and presynaptic terminal. Locally synthesized proteins include factors involved in axonal growth (<xref ref-type="bibr" rid="ref72">Lee et al., 2018</xref>), axonal viability (<xref ref-type="bibr" rid="ref32">Cosker et al., 2016</xref>), and translation (<xref ref-type="bibr" rid="ref49">Fusco et al., 2021</xref>). Axonal translation contributes not only to developing or regenerating axons, but also plays a key regulatory and homeostatic role in mature axons (<xref ref-type="bibr" rid="ref106">Shigeoka et al., 2016</xref>; <xref ref-type="bibr" rid="ref95">Ostroff et al., 2019</xref>; reviewed in <xref ref-type="bibr" rid="ref67">Kim and Jung, 2020</xref>). The axon of upper and lower motor neurons often spans long distances; long axons have an absolute requirement for local response mechanisms largely independent of the cell body &#x2013; indeed, in a meter-long axon, this compartment accounts for well over 99% of the total neuronal volume (reviewed in <xref ref-type="bibr" rid="ref101">Ragagnin et al., 2019</xref>). These features likely accentuate an axon&#x2019;s susceptibility to stressful conditions; indeed, several lines of evidence suggest that ALS is a distal axonopathy, characterized by axonal impairment, which precedes motor neuron degeneration and the onset of clinical signs (<xref ref-type="bibr" rid="ref43">Fischer et al., 2004</xref>; <xref ref-type="bibr" rid="ref86">Moloney et al., 2014</xref>).</p>
<p>The alteration of local mRNA translation in the axon may be a decisive factor in ALS progression, possibly affecting various cellular responses independently of the neuronal soma. For example, oxidative stress is a hallmark of ALS motor neurons, and an increase in reactive oxygen species (ROS) levels and ROS-associated damage have been reported in ALS (<xref ref-type="bibr" rid="ref30">Colombrita et al., 2009</xref>; reviewed in <xref ref-type="bibr" rid="ref11">Barber and Shaw, 2010</xref>; <xref ref-type="bibr" rid="ref2">Altman et al., 2021</xref>; <xref ref-type="bibr" rid="ref73">Lehmkuhl et al., 2021</xref>; <xref ref-type="bibr" rid="ref124">Wong et al., 2021</xref>). While non-cell-autonomous mechanisms play important roles in the pathogenesis of this disorder or in its mitigation (reviewed in <xref ref-type="bibr" rid="ref13">Beers et al., 2006</xref>; <xref ref-type="bibr" rid="ref81">Marchetto et al., 2008</xref>; <xref ref-type="bibr" rid="ref119">Wang et al., 2011</xref>; <xref ref-type="bibr" rid="ref74">Liao et al., 2012</xref>; <xref ref-type="bibr" rid="ref78">Liu and Wang, 2017</xref>), little is known about cell-autonomous signaling events controlling oxidative stress secondary to TDP-43 proteinopathy, and even less about the specific roles played by axons in the response to this condition.</p>
<p>Likewise, synaptic activity may be strictly dependent on local translation in the axon of long-range projection neurons. Indeed, it has been established that mature axons are enriched in transcripts involved in synaptic transmission. Dysregulation of proteins involved in neurotransmitter release have been shown to precede denervation (<xref ref-type="bibr" rid="ref69">Krishnamurthy and Pasinelli, 2021</xref>); hence, synaptic dysfunction may be a crucial factor in ALS onset and progression. Excitatory glutamatergic synapses have received special attention in the ALS field (<xref ref-type="bibr" rid="ref50">Genc et al., 2016</xref>; <xref ref-type="bibr" rid="ref45">Fogarty et al., 2016a</xref>,<xref ref-type="bibr" rid="ref47">b</xref>; <xref ref-type="bibr" rid="ref46">Fogarty et al., 2017</xref>; <xref ref-type="bibr" rid="ref56">Handley et al., 2017</xref>; <xref ref-type="bibr" rid="ref63">Jiang et al., 2017</xref>); however, whereas numerous observations of early postsynaptic spine degeneration have been made, evidence is sparse regarding molecular and functional changes at the presynaptic terminal of corticospinal motor neurons.</p>
<p>Here, we describe a study conducted on homogeneous cultures of mouse cortical neurons (upper motor neurons), expressing a human TDP-43 fusion protein, wt or mutant, which accumulates in the cytoplasm in the form of insoluble aggregates, unlike the corresponding native proteins. This feature allows us to propose our transduced neurons as the first primary culture models of ALS-proteinopathy, characterized by a global impairment in axonal protein synthesis, an increase in oxidative stress, and defects in presynaptic function and electrical activity.</p>
</sec>
<sec sec-type="results" id="sec2">
<title>Results</title>
<sec id="sec3">
<title>An <italic>in vitro</italic> model of deep-layer glutamatergic neurons</title>
<p>To investigate the molecular mechanisms involved in the onset and progression of TDP-43 proteinopathy, we developed an <italic>in vitro</italic> model of highly homogeneous murine upper motor neurons (UMNs), i.e., glutamatergic neurons of layers V and VI, amenable to lentiviral transduction with human TDP-43, wild-type (wt) or carrying an ALS-mutation (<xref ref-type="bibr" rid="ref52">Gitcho et al., 2008</xref>). To obtain primary cortical cultures enriched in glutamatergic neurons of layers V and VI, cells were isolated from the cerebral cortex of mouse embryos harvested at embryonic day 14.5 (E14.5), a developmental stage characterized <italic>in vivo</italic> by a low number of GABAergic neurons and glial cells in the prospective cerebral cortex. Indeed, the immunostaining performed at 3 DIV (<xref rid="SM1" ref-type="supplementary-material">Supplementary Figure 1A</xref>) revealed that virtually all cells were positive for the neuron-specific &#x03B2;3-tubulin (Ab: TuJ1), and 97% of them stained double-positive for the T-Box Brain Transcription Factor 1 (TBR1), an early marker of deep-layer glutamatergic neurons (<xref ref-type="bibr" rid="ref12">Bedogni et al., 2010</xref>). Moreover, about 64% of neuronal cells were double-positive for TuJ1 (neuron-specific type III beta tubulin) and COUP-TF-interacting protein 2 (CTIP2), a transient marker of neurons located in cortical layers V and VI (reviewed in <xref ref-type="bibr" rid="ref87">Molyneaux et al., 2007</xref>). To quantify the GABAergic component of these cultures, we immunostained these cells for glutamic acid decarboxylase-65 (GAD65). As shown in <xref rid="SM1" ref-type="supplementary-material">Supplementary Figure 1B</xref> (left), GAD65-positive cells were virtually absent, while they were abundant in neurons harvested at a later developmental stage (E17.5; <xref rid="SM1" ref-type="supplementary-material">Supplementary Figure 1B</xref>, right). Moreover, the results of EdU incorporation revealed that, while a small number of proliferating progenitors were still present at 2 DIV, all cells lost the ability to replicate DNA at 7 DIV (<xref rid="SM1" ref-type="supplementary-material">Supplementary Figure 1C</xref>).</p>
<p>Finally, we evaluated the presence of glial cells, which are mostly produced at later stages of cortical development. TuJ1 immunostaining, combined with antibodies against specific glial markers (glial fibrillary acidic protein, GFAP, for astrocytes; oligodendrocyte marker 4, O4, for oligodendrocyte precursors; ionized calcium binding adaptor molecule 1, IBA1, for microglia) revealed the virtual absence of all glial cell types in our mouse UMN cultures (<xref rid="SM1" ref-type="supplementary-material">Supplementary Figure 1D</xref>, positive controls in <xref rid="SM1" ref-type="supplementary-material">Supplementary Figures 1E</xref>&#x2013;<xref rid="SM1" ref-type="supplementary-material">G</xref>).</p>
<p>In summary, E14.5 cortical neuronal cultures are strongly enriched in postmitotic glutamatergic neurons of deep cortical layers, from which the corticospinal tract arises, and contain a negligible contribution of glial cells or GABAergic neurons.</p>
</sec>
<sec id="sec4">
<title>Cytoplasmic TDP-43 aggregates in wtTDP-43 and mutTDP-43 neurons</title>
<p>A neuronal model of TDP-43 proteinopathy was produced by transducing the above UMN cultures with lentiviral particles to deliver tRFP alone (ctr neurons) or a human tRFP-TDP-43&#x2009;N-ter fusion protein, either wt or carrying the A315T mutation (henceforth defined wtTDP-43 and mutTDP-43 neurons, respectively); constructs are sketched in <xref ref-type="fig" rid="fig1">Figure 1A</xref>. The transduction efficiency was evaluated using the ArrayScan microscope, as the average percentage of red fluorescent cells over the total cell number (96% for ctr and wtTDP-43 neurons and 97% for mutTDP-43 cells; <xref ref-type="fig" rid="fig1">Figure 1A&#x2032;</xref>). All transduced cells exhibit cytoplasmic aggregates, are viable, and project abundant TuJ1+ neurites (<xref rid="SM1" ref-type="supplementary-material">Supplementary Figure 2</xref>).</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption>
<p>Cytoplasmic aggregate formation in neurons expressing tRFP-TDP-43. <bold>(A)</bold> Schematic representation of ctr, wtTDP-43 and mutTDP-43 constructs. TDP-43 functional domains are also shown. This schematic shows the presence of the fluorescent tag (tRFP) at the N-terminal position of TDP-43. NLS, Nuclear Localization Sequence; RRM1, RRM2, RNA Recognition Motif-1 and -2; LCD, low-complexity glycine-rich domain. The A315T aa substitution is located in the LCD domain. <bold>(A&#x2032;)</bold> Percentage of transduced neurons analyzed by the ArrayScan microscope on 3 independent experiments (<italic>n</italic>&#x2009;=&#x2009;12,877 for ctr, 9,381 wtTDP-43 and 11,634 mutTDP-43); each dot corresponds to the average percentage of a single microscope field. <bold>(B)</bold> Western blot of protein lysates derived from ctr, wtTDP-43 and mutTDP-43 neurons immunostained with an Ab detecting both human and murine TDP-43. An anti-calnexin Ab was used as a loading control. The ~75&#x2009;kDa band (upper solid arrow), corresponds to the product of tRFP N-terminally fused with human TDP-43 (wt or A315T); the ~48&#x2009;kDa band corresponds to endogenous murine TDP-43 (lower solid arrow). Another band (~63&#x2009;kDa) is present in TDP-43-overexpressing neurons, likely representing a C-terminal cleavage product of the fusion protein. Upon a longer exposure, two additional bands appear (empty arrows). <bold>(B&#x2032;)</bold> The graph shows the ratio of total TDP-43 levels (human + endogenous mouse protein) to endogenous TDP-43 levels in ctr cells. Panel <bold>(B&#x2033;)</bold> shows the normalized level of endogenous TDP-43 in TDP-43-overexpressing neurons relative to ctr ones. Values are expressed as mean &#x00B1; SEM; <bold>B&#x2032;</bold>: <italic>n</italic>&#x2009;=&#x2009;3; <bold>B&#x2033;</bold>: <italic>n</italic>&#x2009;=&#x2009;4; Kruskal-Wallis test (non-parametric), <sup>&#x002A;&#x002A;</sup><italic>p</italic>&#x2009;&#x003C;&#x2009;0.01. <bold>(C)</bold> Ctr, wtTDP-43 and mutTDP-43 neurons at 14 DIV, immunostained with an Ab detecting both human and murine TDP-43 (green). In ctr neurons, tRFP is concentrated mostly in the nucleus, while exogenous tRFP-TDP-43 (wt or A315T) is highly enriched in the cytoplasm of wtTDP-43 and mutTDP-43 neurons, forming aggregates. Size bar: 5&#x2009;&#x03BC;m. <bold>(D)</bold> wtTDP-43 and mutTDP-43 aggregates, revealed by tRFP fluorescence, are found not only in cell bodies but also in neurites (see magnification in insets). Size bar: 5&#x2009;&#x03BC;m.</p>
</caption>
<graphic xlink:href="fncel-17-1253543-g001.tif"/>
</fig>
<p>We then assessed the relative expression levels of the exogenous TDP-43 fusion proteins and investigated their subcellular localization, since the cytoplasmic accumulation of TDP-43 is a key feature of ALS neurons (<xref ref-type="bibr" rid="ref114">Suk and Rousseaux, 2020</xref>). Biochemical analysis, performed on UMN lysates with an antibody recognizing both human and murine TDP-43, detected the expression of total TDP-43 protein (about 4-times higher than the endogenous protein in ctr cells; <xref ref-type="fig" rid="fig1">Figure 1B</xref>, solid arrows, quantified in <xref ref-type="fig" rid="fig1">Figure 1B&#x2032;</xref>); notably, the level of endogenous murine TDP-43 is somewhat reduced in wtTDP-43 and mutTDP-43 neurons, probably due to negative post-transcriptional autoregulation (<xref ref-type="bibr" rid="ref8">Ayala et al., 2011</xref>; <xref ref-type="bibr" rid="ref7">Avendano-Vazquez et al., 2012</xref>; <xref ref-type="fig" rid="fig1">Figure 1B&#x2032;&#x2032;</xref>). A ~65&#x2009;kDa band likely represents a degradation product of the fusion protein. Furthermore, a more prolonged exposure of chemiluminescence-stained membranes revealed, both in wtTDP-43 and mutTDP-43 neurons, the presence of TDP-43 proteolytic fragments, a typical hallmark of ALS neurons (<xref ref-type="fig" rid="fig1">Figure 1B</xref>, empty arrows; <xref ref-type="bibr" rid="ref93">Neumann et al., 2006</xref>).</p>
<p>To further characterize TDP-43 expression, we set up a subcellular fractionation protocol to separate nuclear from soluble and insoluble cytosolic fractions (<xref rid="SM1" ref-type="supplementary-material">Supplementary Figure 3A</xref>). The results of western blotting performed on subcellular lysates display an enrichment of exogenous wtTDP-43 and mutTDP-43 proteins in the insoluble fraction (upper solid arrow; <xref rid="SM1" ref-type="supplementary-material">Supplementary Figure 3B</xref>); interestingly, 25&#x2009;kDa degradation products are restricted to the insoluble fraction (empty arrow; <xref rid="SM1" ref-type="supplementary-material">Supplementary Figure 3B</xref>). The cytoplasmic accumulation of exogenous TDP-43, a key feature of ALS neurons (<xref ref-type="bibr" rid="ref114">Suk and Rousseaux, 2020</xref>), was confirmed by immunocytochemistry, revealing a predominantly nuclear localization of the endogenous TDP-43 in ctr neurons (<xref ref-type="bibr" rid="ref93">Neumann et al., 2006</xref>) in contrast with an enrichment of both wtTDP-43 and mutTDP-43 in cytoplasmic aggregates (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). Numerous cytoplasmic aggregates are also found in neurites (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). Importantly, cytoplasmic localization is not dependent on overexpression, since an overexpressed TDP-43 fused to a shorter tag (see methods) maintains a nuclear distribution (<xref rid="SM1" ref-type="supplementary-material">Supplementary Figure 3C</xref>).</p>
<p>Our findings are reminiscent of neuronal cytoplasmic aggregates observed in all cortical layers in motor neuron disease with frontotemporal dementia (<xref ref-type="bibr" rid="ref79">Mackenzie et al., 2011</xref>). Notably, expression of RFP alone does not lead to aggregates; thus, the observed effects are TDP-43-specific. Overall, our results indicate that neurons expressing RFP-TDP-43 fusion proteins recapitulate several key features of TDP-43 proteinopathy within the brief lifespan of a primary neuron culture. To our knowledge, ours is the first <italic>in-vitro</italic> neuronal model of TDP-43 proteinopathy.</p>
</sec>
<sec id="sec5">
<title>Exogenous TDP-43 is recruited to RNA granules</title>
<p>The analysis of tissue samples obtained from 97% of ALS patients has revealed the presence of TDP-43 pathologic inclusions (<xref ref-type="bibr" rid="ref92">Neumann, 2009</xref>; <xref ref-type="bibr" rid="ref76">Ling et al., 2013</xref>). TDP-43 is known to bind other RBPs (e.g., fragile X mental retardation protein, FMRP, and neuron-specific Elav-like Hu RNA-binding protein D, HuC/D), generating granules that transport mRNAs along neurites (<xref ref-type="bibr" rid="ref42">Fallini et al., 2012</xref>). Therefore, we investigated the nature of exogenous TDP-43 aggregates in our UMN cultures by immunostaining wtTDP-43 and mutTDP-43 neurons with an HuC/D-specific Ab. HuD is involved in mRNA stability, splicing, and positive regulation of translation (<xref ref-type="bibr" rid="ref39">Diaz-Garcia et al., 2021</xref>). Our results reveal that exogenous TDP-43 granules partially colocalize with HuC/D (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). The degree of colocalization, plotted in <xref ref-type="fig" rid="fig2">Figure 2A&#x2032;</xref>, shows that HuD colocalizes slightly more frequently with wtTDP-43 than with mutTDP-43.</p>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption>
<p>tRFP-TDP-43 is recruited by RNA granules. <bold>(A)</bold> Immunofluorescent staining of wtTDP-43 and mutTDP-43 neurons with an anti-HuC/D antibody. HuC/D (green) partially colocalizes with fluorescent tRFP-TDP-43 aggregates (wt or A315T; red) as shown by arrowheads in insets. <bold>(A&#x2032;)</bold> Dots in histogram indicate the percentage of HuC/D-tRFP colocalization in each individual cell examined; mean positive Pearson&#x2019;s correlation coefficient: <italic>r&#x2009;=</italic> 0.56&#x2009;&#x00B1;&#x2009;0.016 (wtTDP-43); 0.55&#x2009;&#x00B1;&#x2009;0.017 (mutTDP-43; Mean&#x2009;&#x00B1;&#x2009;SEM, <italic>n</italic>&#x2009;=&#x2009;3). <bold>(B)</bold> Immunofluorescence of ctr, wtTDP-43 and mutTDP-43 neurons with anti-G3BP1 under physiological conditions (left) and after heat shock (right).</p>
</caption>
<graphic xlink:href="fncel-17-1253543-g002.tif"/>
</fig>
<p>To assess whether exogenous TDP-43-positive cytoplasmic granules colocalize with stress granules (reviewed in <xref ref-type="bibr" rid="ref38">Dewey et al., 2012</xref>), we immunostained cells for Ras-GTPase-activating protein SH3 domain-binding protein 1 (G3BP1)], a known component of stress granules that is involved in their formation (<xref ref-type="bibr" rid="ref83">Matsuki et al., 2013</xref>). Under basal conditions (37&#x00B0;C), G3BP1 signal displayed a diffuse pattern in ctr, wtTDP-43 and mutTDP-43 neurons alike, while heat shock treatment (43&#x00B0;C, 30&#x2009;min) generated G3BP1+ granules that contained exogenous TDP-43 (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). This result recapitulates findings obtained in cells undergoing a non-lethal injury (<xref ref-type="bibr" rid="ref60">Higashi et al., 2013</xref>) and suggests that in our conditions TDP-43 does not promote SG formation <italic>per se</italic>, but retains the ability to be recruited to newly assembled stress granules, once they form (<xref ref-type="bibr" rid="ref30">Colombrita et al., 2009</xref>), although TDP-43 oligomerization and aggregation takes place in the cytoplasm separate from them (<xref ref-type="bibr" rid="ref112">Streit et al., 2022</xref>).</p>
</sec>
<sec id="sec6">
<title>Global downregulation of protein synthesis in the axon of TDP-43-overexpressing mouse cortical neurons</title>
<p>In parallel to the functional analysis of our cellular models (see below), we took advantage of a transcriptome and translatome analysis (G. Viero and co-workers, Institute of Biophysics, CNR Unit at Trento; GEO ID: GSE239419) conducted on cell-body and axonal compartments, to explore the gene expression and mRNA translation landscape at a systems biology level. To this end, cortical neurons were plated on microfluidic chambers (<xref ref-type="bibr" rid="ref115">Taylor et al., 2005</xref>), consisting of two main channels separated by 450&#x2009;&#x03BC;m-long microgrooves (see Methods); cell bodies are too large to enter them, while dendrites are too short to extend beyond them.</p>
<p>The physical separation of axonal and somatodendritic compartments was demonstrated by immunofluorescence in untransduced neurons, cultured in microfluidic chambers for 9 DIV and immunostained with Abs for Microtubule Associated Protein 2 (MAP2), a dendrite-specific marker, and for TuJ1, which decorates dendrites, cell bodies and axons alike. As shown in <xref rid="SM1" ref-type="supplementary-material">Supplementary Figure 4</xref>, MAP2 signal is sharply restricted to the whole-cell channel, while axons extend the right channel and are labeled by TuJ1 only.</p>
<p>To ask whether exogenous TDP-43 might bind to components of the mRNA translation machinery, possibly affecting local mRNA translation in the axon, we immunostained wtTDP-43- and mutTDP-43-expressing neurons with antibodies against small and large ribosomal subunit proteins (RPS6 and RPL26, respectively). As shown in <xref ref-type="fig" rid="fig3">Figure 3A</xref> and histogram in <xref ref-type="fig" rid="fig3">Figure 3A&#x2032;</xref>, 20% of granules, on average, colocalize with RPS6 and RPL26, in both wtTDP-43 and mutTDP-43 neurons. This finding suggests that TDP-43 aggregates may sequester ribosome components and/or interfere with ribosomal transport, likely resulting in an overall decrease of mRNA translation.</p>
<fig position="float" id="fig3">
<label>Figure 3</label>
<caption>
<p>Axonal protein synthesis is reduced in wtTDP-43 and mutTDP-43 neurons. <bold>(A)</bold> A fraction of small and large subunit ribosomal proteins (RPS6 and RPL26, respectively) colocalize with aggregates of RFP-tagged human TDP-43, both wild type and mutant (see arrowheads in insets). <bold>(A&#x2032;)</bold> Dots in histograms indicate the percentage of colocalization in each individual cell examined; mean positive Pearson&#x2019;s correlation coefficient: for RPS6, <italic>r&#x2009;=</italic> 0.41&#x2009;&#x00B1;&#x2009;0.013 (wtTDP-43); 0.34&#x2009;&#x00B1;&#x2009;0.009 (mutTDP-43); for RPL26, <italic>r&#x2009;=</italic> 0.35&#x2009;&#x00B1;&#x2009;0.013 (wtTDP-43); 0.33&#x2009;&#x00B1;&#x2009;0.012 (mutTDP-43); (Mean&#x2009;&#x00B1;&#x2009;SEM, <italic>n</italic>&#x2009;=&#x2009;3). <bold>(B)</bold> RPL26 protein abundance is reduced in the cell body (left) and axon (right) of cells expressing human TDP-43, wt or mutant. Differences and their statistical significance are plotted in <bold>B&#x2032;</bold>, where each dot corresponds to an individual cell or axon examined. Mean&#x2009;&#x00B1;&#x2009;SEM, <italic>n</italic>&#x2009;=&#x2009;3, Mann&#x2013;Whitney test (non-parametric), <sup>&#x002A;&#x002A;&#x002A;&#x002A;</sup>value of <italic>p</italic> &#x003C; 0.0001. <bold>(C)</bold> Global protein synthesis, expressed as the intensity of puromycin-positive signal, is decreased in the cell body, axon and growth cone of cells expressing human TDP-43, wt or mutant (see results for explanation). Differences and their statistical significance are plotted in <bold>C&#x2032;</bold>, where each dot corresponds to an individual cell/axon/growth cone (Mean&#x2009;&#x00B1;&#x2009;SEM, <italic>n</italic>&#x2009;=&#x2009;3, Mann&#x2013;Whitney test (non-parametric), <sup>&#x002A;</sup>value of <italic>p</italic>&#x003C;0.05, <sup>&#x002A;&#x002A;</sup>value of <italic>p</italic>&#x003C;0.01, <sup>&#x002A;&#x002A;&#x002A;&#x002A;</sup>value of <italic>p</italic>&#x003C;0.0001). <bold>(D)</bold> Here and in subsequent figures, the Venn diagrams on the left and in the center show the number of DEGs in the axon (light blue) and soma (pink) of wtTDP-43 and mutTDP-43 neurons, respectively; the intersection between blue diagrams on the right indicates axonal DEGs shared by the two populations, and listed in <xref ref-type="table" rid="tab2">Table 2</xref>. Venn diagrams shown here describe the numbers of polysome-engaged mRNAs, involved in various aspects of mRNA translation, whose abundance is decreased in wtTDP-43 and mutTDP-43 axons vs. ctr ones. Note the high number of axonal DEGs belonging to gene ontologies related to mRNA translation.</p>
</caption>
<graphic xlink:href="fncel-17-1253543-g003.tif"/>
</fig>
<p>Therefore, we set out to determine whether wtTDP- and mutTDP-expressing neurons showed decreased axonal levels of RPL26, a component of the ribosomal large subunit for which efficient antibodies are available, relative to control axons. To this end, we immunostained wtTDP-43, mutTDP-43 and ctr neurons, cultured in microfluidic chambers for 9 DIV, with antibodies to RPL26 and the axonal marker TuJ1. RPL26 signal was then quantified in the axon and cell body. As shown in <xref ref-type="fig" rid="fig3">Figures 3B</xref>,<xref ref-type="fig" rid="fig3">B&#x2032;</xref>, RPL26 protein levels are decreased in both axons and cell bodies of wtTDP-43 and mutTDP-43 neurons relative to ctr neurons. In conclusion, the decrease of axonal RPL26 suggests that the overall amount of 60S ribosomal subunit may be significantly reduced in wtTDP-43 and mutTDP-43 axons and cell bodies, relative to ctr neurons.</p>
<p>Accordingly, we asked if protein synthesis might be globally defective in these neurons. To assess whether mRNA translation is affected in wtTDP-43 and mutTDP-43 neurons, we carried out a puromycylation assay (<xref ref-type="bibr" rid="ref35">David et al., 2012</xref>). By quantitative immunofluorescence methods, we evaluated puromycin incorporation as a measure of ongoing protein synthesis. As shown in <xref ref-type="fig" rid="fig3">Figures 3C</xref>,<xref ref-type="fig" rid="fig3">C&#x2032;</xref>, in both wtTDP-43 and mutTDP-43 neurons puromycin signal is significantly reduced in the cell body, axon and growth cone alike, similar to findings previously observed at the neuromuscular junction (<xref ref-type="bibr" rid="ref2">Altman et al., 2021</xref>).</p>
<p>To identify transcripts downregulated in the axon of wtTDP-43 and mut-TDP-43 neurons, next-generation sequencing (NGS) of the axon- and cell-body-specific polysome-engaged mRNAs (polysome profiling) from TDP-43-overexpressing neurons was performed by tag-free polysome isolation through a miniaturized sucrose gradient (<xref rid="SM1" ref-type="supplementary-material">Supplementary Figure 5</xref>; see Methods, <xref ref-type="bibr" rid="ref91">Negro et al., 2018</xref>).</p>
<p>We found that polysomal mRNA levels are robustly dysregulated in both human TDP-43-expressing neuronal populations compared to control neurons, with 1,598 and 1,601 differentially expressed genes (DEGs) for wtTDP-43 and mutTDP-43, respectively. Compared to the number of DEGs in the cell body alone (467 in human TDP43 and 513 in mouse TDP43), more changes occur in the axon, accounting for 65 and 68% of total DEGs, respectively. Importantly, 1,043/1,131 (92%) axonal DEGs in wtTDP-43 and 877/1,088 (81%) in mutTDP-43 are downregulated, suggesting a widespread loss of mRNAs engaged in local translation (<xref ref-type="table" rid="tab1">Table 1</xref>).</p>
<table-wrap position="float" id="tab1">
<label>Table 1</label>
<caption>
<p>Upregulated and downregulated DEGs in human TDP-43 expressing neurons vs. controls.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th/>
<th/>
<th align="center" valign="top">Cell body</th>
<th align="center" valign="top">Axon</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle" rowspan="3">wtTDP-43</td>
<td align="left" valign="middle">Upregulated</td>
<td align="center" valign="middle">86</td>
<td align="center" valign="middle">88</td>
</tr>
<tr>
<td align="left" valign="middle">Downregulated</td>
<td align="center" valign="middle">381</td>
<td align="center" valign="middle">1,043</td>
</tr>
<tr>
<td align="left" valign="middle">Total</td>
<td align="center" valign="middle">467</td>
<td align="center" valign="middle">1,131</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="3">mutTDP-43</td>
<td align="left" valign="middle">Upregulated</td>
<td align="center" valign="middle">85</td>
<td align="center" valign="middle">211</td>
</tr>
<tr>
<td align="left" valign="middle">Downregulated</td>
<td align="center" valign="middle">428</td>
<td align="center" valign="middle">877</td>
</tr>
<tr>
<td align="left" valign="middle">Total</td>
<td align="center" valign="middle">513</td>
<td align="center" valign="middle">1,088</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Of all downregulated polysome-engaged transcripts, a large number belonged to gene ontologies related to protein synthesis and displayed lower levels in wtTDP-43 and mutTDP-43 neurons (289 and 313, respectively), compared to control neurons (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). Of these, 47 axon-specific polysome-engaged DEGs were shared between the two overexpressing populations, and are listed in <xref ref-type="table" rid="tab2">Table 2</xref> and <xref rid="SM1" ref-type="supplementary-material">Supplementary Table 1</xref>. Remarkably, in wtTDP-43 neurons, axon-specific polysomal DEGs make up 97.6% of the total, whereas in mutTDP-43 cells axon-specific DEGs amount to 33.9% of the total.</p>
<table-wrap position="float" id="tab2">
<label>Table 2</label>
<caption>
<p>Downregulated axonal mRNAs shared by wtTDP-43 and mutTDP-43 neurons.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Gene ontology category</th>
<th align="left" valign="top">Genes</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">mRNA translation/protein synthesis</td>
<td align="left" valign="bottom">Celf1, Cnot7, Eef1b2, Eif4g1, Eif4g2, Eif4g3, Eif5a, Fus, Fxr1, Gapdh, Gm6576, Gm8210, Hspa8, Ilf3, Myc, Nop56, Npm1, Pabpc1, Pcbp2, Ptbp1, Pum2, Rbm4, Rbm4b, Rock2, Rpl11, Rpl14, Rpl22, Rpl3, Rpl30, Rpl35a, Rpl5, Rpl6, Rpl7, Rpl9, Rplp2, Rps12, Rps13, Rps15a, Rps2-ps6, Rps24, Rps7, Rps8, Rps9, Snu13, Srp54b, Xpo1, Zfp706</td>
</tr>
<tr>
<td align="left" valign="middle">Oxidative stress</td>
<td align="left" valign="middle">Becn1, Clcn3, Hsph1, Map3k7, Mapk9, Nfe2l1, Prdx2, Rock2</td>
</tr>
<tr>
<td align="left" valign="middle">Synaptic function</td>
<td align="left" valign="middle">Abi1, Abi2, Abr, Actr3, Adgrl1, Adgrl3, Afdn, Agrn, Agtpbp1, Akap7, Ap1ar, Apbb1, Arhgap21, Arhgef9, Atp2b2, Bsg, Cadm1, Camk2d, Cask, Clcn3, Clta, Copa, Copg2, Cux1, Dclk1, Dlg4, Dlgap1, Dst, Epb41l2, Erbin, Flna, Fus, Fxr1, Gapdh, Gapvd1, Gdi1, Gls, Gnas, Gpm6b, Hnrnpa2b1, Hspa8, Kif3c, Macf1, Malat1, Map2, Map3k7, Mapk9, Mia2, Ncoa2, Ndrg4, Nfia, Nrxn2, Pak3, Pebp1, Plekha5, Psma3, Ptk2, Rapgef1, Rims1, Rnf10, Rock2, Scn1a, Scn8a, Sgip1, Sh3kbp1, Stxbp1, Syne1, Synj1, Syt7, Tln2, Tmcc1, Tmod2, Tnik, Ube2i, Usp48, Ywhaq, Zfp365</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="sec7">
<title>Increased oxidative stress in TDP-43-overexpressing neurons</title>
<p>Two other gene ontologies affected by TDP-43 overexpression were related to synaptic function and to the response to oxidative stress. The presence of high levels of ROS and the consequent oxidative stress-dependent neuronal damage are among the main hallmarks of ALS (<xref ref-type="bibr" rid="ref11">Barber and Shaw, 2010</xref>). Therefore, we asked whether our neuronal model of TDP-43 proteinopathy exhibits this characteristic aspect of neurotoxicity. We performed this analysis in neurons loaded with H<sub>2</sub>DCFDA (DCF), both under untreated conditions (<xref ref-type="fig" rid="fig4">Figure 4A</xref>) and upon mild iron overload (48&#x2009;h in the presence of 20&#x2009;&#x03BC;M ferric iron); the latter provides information about the ability of neurons to counteract and detoxify an oxidative condition, promoted here by the iron-catalyzed Fenton reaction. Not only did our results show a significant increase in basal ROS levels in both overexpressing populations compared to ctr neurons (<xref ref-type="fig" rid="fig4">Figure 4B</xref>, red dot bars), but they also revealed a sharply increased oxidative effect of iron overload in TDP-43 overexpressing neurons vs. ctr cells (<xref ref-type="fig" rid="fig4">Figure 4B</xref>, green dot bars). As mentioned, numerous polysome-engaged somatic and axonal mRNAs involved in the response to oxidative stress are downregulated in neurons expressing wtTDP-43 (78) and mutTDP-43 (74), compared to ctr neurons. Notably, a majority of differences observed in wtTDP-43 neurons were relative to axonal mRNAs, suggesting that locally translated axonal mRNAs may play a major and as yet uncharacterized role in the detoxification of oxidative stress. Out of the axonal DEGs, 9 were shared between wtTDP-43 and mutTDP-43 neurons (<xref ref-type="fig" rid="fig4">Figure 4C</xref>; <xref ref-type="table" rid="tab2">Table 2</xref>; <xref rid="SM1" ref-type="supplementary-material">Supplementary Table 1</xref>), and include transcripts encoding nucleotide exchange factors for chaperone proteins, kinases, ER membrane sensors involved in stress response and <italic>Prdx2</italic>, encoding an abundant cytosolic peroxidase.</p>
<fig position="float" id="fig4">
<label>Figure 4</label>
<caption>
<p>Impairment of the response to oxidative stress in neurons wtTDP-43 and mutTDP-43 neurons. <bold>(A)</bold> Representative images of ctr, wtTDP-43 and mutTDP-43 neurons loaded with DCF (green) shown as rainbow look-up table (LUT) values. <bold>(B)</bold> Graph showing DCF fluorescence intensity of ctr, wtTDP-43 and mutTDP-43 relative to untreated (UNT) ctr neurons, in the absence (red) or presence (green) of Fe<sup>3+</sup> treatment. Data are expressed as mean&#x2009;&#x00B1;&#x2009;SEM, from 4 or 5 biological replicates; each dot corresponds to an individual microscope field (<italic>n</italic>&#x2009;=&#x2009;48 fields for each experimental condition with an average of 60&#x2013;70 neurons/field); Two-way ANOVA test <sup>&#x002A;</sup><italic>p</italic>&#x2009;&#x003C;&#x2009;0.05; <sup>&#x002A;&#x002A;&#x002A;</sup><italic>p</italic>&#x2009;&#x003C;&#x2009;0.005; <sup>&#x002A;&#x002A;&#x002A;&#x002A;</sup><italic>p</italic>&#x2009;&#x003C;&#x2009;0.0001. <bold>(C)</bold> Venn diagrams reporting the numbers of downregulated polysomal DEGs involved in the response to oxidative stress. Note the high number of mRNAs, belonging to gene ontologies related to oxidative stress, which show differential abundance in the axon.</p>
</caption>
<graphic xlink:href="fncel-17-1253543-g004.tif"/>
</fig>
</sec>
<sec id="sec8">
<title>Impaired spontaneous electrical activity, calcium handling and synaptic function in TDP-43 overexpressing neurons</title>
<p>As mentioned, gene ontologies related to synaptic function are affected in wtTDP-43 and mutTDP-43 neurons, compared to ctr neurons. Synaptic abnormalities have been reported in the neurons of both ALS patients and animal models (primarily <italic>SOD1</italic> transgenics), ranging from morphological alterations to functional impairment, thereby supporting the hypothesis that ALS might either result from, or be exacerbated by synaptic dysfunction (<xref ref-type="bibr" rid="ref44">Fogarty, 2019</xref>).</p>
<p>Since synaptic alterations seem to involve primarily glutamatergic neurons, as suggested by recent genetic studies (<xref ref-type="bibr" rid="ref117">van Rheenen et al., 2021</xref>), we investigated whether wtTDP-43 and mutTDP-43 overexpression could induce synaptic impairment in our cultures. Whole-cell patch clamp experiments revealed spontaneous, AMPA-dependent mini excitatory postsynaptic currents (mEPSCs), recorded at a holding potential of &#x2212;70&#x2009;mV and in the presence of a Na<sup>+</sup> channel blocker (TTX, 1&#x2009;&#x03BC;M) and GABA<sub>A</sub> receptor antagonist (gabazine, 10&#x2009;&#x03BC;M). No significant differences were detected in the average amplitude, decay time constant, or frequency of mEPSCs (<xref rid="SM1" ref-type="supplementary-material">Supplementary Figure 6</xref>). However, spontaneous synaptic activity in TTX- and gabazine-free ACSF revealed recurrent bursts of postsynaptic currents (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). While burst duration was not affected by TDP-43 overexpression (<xref ref-type="fig" rid="fig5">Figure 5A&#x2032;&#x2032;</xref>; either wild-type or mutant), the frequency of bursts was significantly reduced in both overexpressing populations compared to ctr neurons (<xref ref-type="fig" rid="fig5">Figure 5A&#x2032;</xref>).</p>
<fig position="float" id="fig5">
<label>Figure 5</label>
<caption>
<p>Impairment of spontaneous burst firing, calcium responses and synaptic vesicle exocytosis in neurons expressing human TDP-43. <bold>(A)</bold> Top left: examples of spontaneous compound postsynaptic current (PSC) bursts recorded in ctr, wtTDP-43, and mutTDP-43 cultures. Top right: individual PSC bursts recorded in voltage clamp mode at a vh of &#x2212;70&#x2009;mV correlate with spontaneous action potential bursts recorded in current clamp in a different cell. <bold>(A&#x2032;)</bold> Summary plots of average burst frequencies. <bold>(A&#x2033;)</bold> Average duration of individual bursts. wtTDP-43 and mutTDP-43 show decreased burst frequency relative to ctr, while no difference in individual burst duration was observed (Mean &#x00B1; SEM, of 46 ctr neurons, 31 wtTDP-43 neurons and 41 mutTDP-43 neurons, from 12, 11, and 10 experiments, respectively), Mann Whitney <italic>U</italic>-Test (non-parametric), ns&#x2009;=&#x2009;<italic>p</italic>&#x2009;&#x003E;&#x2009;0.05, <sup>&#x002A;</sup><italic>p</italic>&#x2009;&#x003C;&#x2009;0.05. <bold>(B)</bold> Graphs showing fura-2340/380&#x2009;nm ratio of fluorescence intensity in ctr, wtTDP-43 and mutTDP-43 neurons under basal conditions (graph on the left) and at the peak of response after glutamate stimulation [graph on the right; Mean &#x00B1; SEM of 176 ctr neurons, 158 wtTDP-43 neurons, and 151 mutTDP-43 neurons, from 5 biological replicates, Kruskal-Wallis test (non-parametric), <sup>&#x002A;&#x002A;</sup><italic>p</italic>&#x2009;&#x003C;&#x2009;0.001, <sup>&#x002A;&#x002A;&#x002A;&#x002A;</sup><italic>p</italic>&#x2009;&#x003C;&#x2009;0.0001]. <bold>(C)</bold> Transmission electron microscopy analysis reveals synaptic boutons and the corresponding postsynaptic side. Note a significant reduction of vesicle numbers in mutTDP-43 neurons <bold>(C&#x2032;)</bold> Synaptic vesicle counts were performed on electron microscopy images from 4 different biological replicates using ImageJ software. In particular we counted 28 images for tRFP (<italic>n</italic>&#x2009;=&#x2009;1,536 synaptic vesicles), 26 for wtTDP-43 (<italic>n</italic>&#x2009;=&#x2009;1,099 synaptic vesicles); 40 for mutTDP-43 (<italic>n</italic>&#x2009;=&#x2009;1,032 synaptic vesicles); Mean &#x00B1; SEM, Kruskal-Wallis test (non-parametric), <sup>&#x002A;&#x002A;&#x002A;&#x002A;</sup><italic>p</italic>&#x2009;&#x003C;&#x2009;0.0001. <bold>(D)</bold> Representative images showing FM1-43 fluorescence intensity as rainbow LUTs at two time points of the FM1-43 assay. The left image shows a neuron after treatment with 10&#x2009;&#x03BC;M FM1-43 and 30&#x2009;mM KCl simultaneously to promote internalization of the dye in synaptic vesicles; the right image shows FM1-43 fluorescence intensity 15&#x2009;s after the second stimulus with 30&#x2009;mM KCl, which triggers exocytosis of fluorescence-loaded vesicles. <bold>(D&#x2032;)</bold> The graph shows fluorescence levels of synaptic contacts upon completion of endocytosis (e.g., left panel in <bold>D</bold>), revealing a significant decrease of FM1-43 signal in both wtTDP-43 and mutTDP-43 cells; Mean &#x00B1; SEM, Kruskal-Wallis test (non-parametric, <sup>&#x002A;&#x002A;&#x002A;&#x002A;</sup><italic>p</italic>&#x2009;&#x003C;&#x2009;0.0001). This result parallels the number of vesicles loaded with FM1-43. <bold>(D&#x2033;)</bold> Graph showing the decay of FM1-43 fluorescence relative to time 0, upon addition of the 2nd KCl stimulus, in wtTDP-43 (blue), mutTDP-43 (red) and ctr cells (gray). The downward slope of the curve parallels the rate of exocytosis [Mean &#x00B1; SEM, from 5 biological replicates, Mann&#x2013;Whitney test (non-parametric), <sup>&#x002A;&#x002A;&#x002A;&#x002A;</sup>value of <italic>p</italic> &#x003C; 0.0001, number of analyzed ROI: ctrl&#x2009;=&#x2009;456, wtTDP&#x2009;=&#x2009;384, mutTDP&#x2009;=&#x2009;532]. <bold>(E)</bold> Venn diagrams reporting the numbers of downregulated polysomal DEGs involved in synaptic function. Note the high number of differentially abundant mRNAs, belonging to gene ontologies related to synapses, which show differential abundance in the axon.</p>
</caption>
<graphic xlink:href="fncel-17-1253543-g005.tif"/>
</fig>
<p>The decrease of spontaneous bursting activity observed in TDP-43 overexpressing neurons prompted us to investigate the role of calcium (Ca<sup>2+</sup>) homeostasis in UMNs. To this end, neurons were loaded with the fura-2 calcium dye which, thanks to its ratiometric properties, makes it possible to compare intracellular Ca<sup>2+</sup> levels both at rest and at maximal glutamate (100&#x2009;&#x03BC;M) stimulation. In keeping with the decreased burst frequency, both wtTDP-43 and mutTDP-43 UMNs showed decreased basal levels of intracellular Ca<sup>2+</sup> concentration [Ca<sup>2+</sup>]<sub>i</sub> compared to ctr neurons, therefore potentially affecting spontaneous electrical activity. Notably, the amplitude of [Ca<sup>2+</sup>]<sub>i</sub> response to glutamate stimulation was also significantly reduced in wtTDP-43 but not in mutTDP-43 neurons (<xref ref-type="fig" rid="fig5">Figure 5B</xref>).</p>
<p>The impairment of spontaneous synaptic activity correlates with a depletion of vesicles in presynaptic active zones in TDP-43-overexpressing neurons, as revealed by ultrastructural analysis (<xref ref-type="fig" rid="fig5">Figure 5C</xref>) and by the quantification of presynaptic vesicle numbers (graph in <xref ref-type="fig" rid="fig5">Figure 5C&#x2032;</xref>). To confirm in live neurons the results obtained by electron microscopy, we exploited the properties of the FM1-43 dye (<xref ref-type="bibr" rid="ref4">Amaral et al., 2011</xref>), since the loading and loss of the fluorescent dye provide a reliable measurement of synaptic vesicle retrieval and release in cultured neurons (<xref ref-type="bibr" rid="ref104">Sambri et al., 2020</xref>). Exo-endocytosis was evoked by a first pulse of depolarizing stimulus (30&#x2009;mM KCl added to the bath together with FM1-43 dye; see Methods); after washing the non-vesicle bound FM1-43, we quantified the fluorescence signal within synaptic boutons, correlating with their content of endocytic FM1-43-labeled vesicles (see image in <xref ref-type="fig" rid="fig5">Figure 5D</xref>, left image). The graph in <xref ref-type="fig" rid="fig5">Figure 5D&#x2032;</xref> shows a trend of signal decrease in wtTDP-43 neurons and a sharp decrease in mutTDP-43 cells, indicating, as in graph <xref ref-type="fig" rid="fig5">Figure 5C&#x2019;</xref>, a lower number of vesicles in TDP-43-overexpressing neurons compared to ctr ones. The FM1-43-based experiments also allowed us to analyze the rate of synaptic exocytosis; indeed, after inducing fluorescent dye endocytosis, a second depolarizing KCl pulse caused vesicle exocytosis, evaluated by FM1-43 fluorescence decay over 20&#x2009;s. As shown in <xref ref-type="fig" rid="fig5">Figure 5D</xref> (right) and <xref ref-type="fig" rid="fig5">Figure 5D&#x2032;&#x2032;</xref>mutTDP-43 and, even more so, wtTDP-43 neurons, where calcium alterations are more pronounced, show a major impairment in their rate of exocytosis compared to ctr cells.</p>
<p>Again, a high number of DEGs were observed in the axonal translatome, underlying the key contribution of axonal protein synthesis to the regulation of synaptic activity and maintenance (<xref ref-type="fig" rid="fig5">Figure 5E</xref>). The list of significantly downregulated synaptic mRNAs shared by wtTDP-43- and mutTDP-43 axons includes transcripts encoding synaptic adhesion molecules, regulators of cytoskeletal dynamics, regulatory and structural proteins involved in synaptic vesicle trafficking/recycling (<xref ref-type="table" rid="tab2">Table 2</xref>; <xref rid="SM1" ref-type="supplementary-material">Supplementary Table 1</xref>).</p>
</sec>
</sec>
<sec sec-type="discussion" id="sec9">
<title>Discussion</title>
<p>In this study, we report the generation and functional characterization of mouse UMNs, transduced with wt and mutant forms of TDP-43 for use as neuronal models of TDP-43 proteinopathy. Primary cortical neuron cultures often contain a heterogeneous neuroglial population, which makes it difficult to discriminate neuronal cell-autonomous mechanisms from the effects of glial-neuron interactions. However, the neuronal cultures described here are highly homogeneous and almost entirely comprised of TBR1-positive glutamatergic projection neurons of the deep cortical layers, the cerebral neuron type that is most sensitive to ALS (<xref ref-type="bibr" rid="ref75">Limone et al., 2021</xref>), in the virtual absence of GABAergic neurons or glial cells.</p>
<p>TDP-43 proteinopathy, which manifests itself as nuclear depletion and cytoplasmic accumulation/aggregation of TDP-43, is a very frequently observed feature of ALS (<xref ref-type="bibr" rid="ref6">Arai et al., 2006</xref>; <xref ref-type="bibr" rid="ref93">Neumann et al., 2006</xref>; <xref ref-type="bibr" rid="ref36">de Boer et al., 2020</xref>). While animal models displaying physiological levels of TDP-43 aim at faithfully reproducing the pathophysiology of the disease, they often show a mild phenotype that can be properly analyzed only at late stages. The Q331K TDP-43 knock-in mouse model (<xref ref-type="bibr" rid="ref121">White et al., 2018</xref>) shows almost no motor dysfunction nor TDP-43 proteinopathy, although it exhibits a late cognitive phenotype. Likewise, a knock-in model, carrying the M323K mutation, exhibits a mild muscular phenotype with reduced grip strength only at 2&#x2009;years of age and no TDP-43 pathology in the spinal cord or brain; however, at the molecular level, these mice show alterations in RNA splicing (<xref ref-type="bibr" rid="ref48">Fratta et al., 2018</xref>). Conversely, our primary cultures of UMNs exhibit spontaneous cytoplasmic TDP-43 aggregate formation.</p>
<p>Although the use of fluorescently tagged TDP-43 has been reported to impair its nuclear egress (<xref ref-type="bibr" rid="ref40">Ederle et al., 2018</xref>), this is not the case in our models. Instead, we hypothesize that the size of the RFP-TDP-43 fusion protein may hinder its nuclear import, causing trafficking defects akin to those produced by NLS removal (<xref ref-type="bibr" rid="ref61">Igaz et al., 2011</xref>). This facilitates the formation of cytoplasmic TDP-43 aggregates, which are not observed upon overexpression of RFP alone. This feature is reminiscent of the pathological aggregates observed in the cerebral cortex and spinal cord of familial and sporadic ALS patients (<xref ref-type="bibr" rid="ref79">Mackenzie et al., 2011</xref>; <xref ref-type="bibr" rid="ref39">Diaz-Garcia et al., 2021</xref>), effectively mimicking TDP-43 proteinopathy. Taken together, these features make our primary cultures a useful tool for the study of TDP-43 proteinopathy, within the ephemeral lifespan of a primary culture. Our models provide a solid screening platform suited to produce new evidence amenable to validation in other, more physiological model systems.</p>
<p>While the cytoplasmic aggregates described here are positive for established RNA granule markers (<xref ref-type="bibr" rid="ref108">Sidib&#x00E9; and Vande Velde, 2019</xref>), defining the complete nucleotide and peptide composition of those aggregates will require further studies. In fact, mRNA granules recruit multiple factors. Importantly, TDP-43+ granules recruit other RNA-binding proteins, such as FMRP, IMP and HuD (<xref ref-type="bibr" rid="ref42">Fallini et al., 2012</xref>), possibly sequestering an additional mRNA population via protein&#x2013;protein interactions. Notably, tRFP-TDP-43 fusion proteins form aggregates in the absence of overt cellular stress, indicating that tRFP-TDP-43 overexpression does not <italic>per se</italic> induce acute cellular stress.</p>
<p>Our results suggest that RFP-TDP-43+ granules sequester proteins required for mRNA translation, likely reducing the global rate of protein synthesis in the cell body, dendrites and axon alike. In keeping with this observation, RPL26 protein levels are profoundly reduced in the axon of wtTDP-43 and mutTDP-43 neurons. Moreover, the results of our puromycylation assay directly show an overall decrease in axonal protein synthesis; in fact, the levels of numerous polysome-engaged mRNAs involved in protein synthesis are significantly decreased in the axon of TDP-43 overexpressing neurons. Such mRNAs are deregulated in the axon of both overexpressing populations, and encode, among others, translation initiation factors and RNA-binding proteins. One open question regards the role of transcripts encoding ribosomal proteins in the axon (<xref ref-type="bibr" rid="ref88">Nagano et al., 2020</xref>); recent evidence suggests that they may subserve the repair of damaged ribosomes (<xref ref-type="bibr" rid="ref49">Fusco et al., 2021</xref>).</p>
<p>Our functional analysis also revealed that wtTDP-43 and mutTDP-43 neurons exhibit increased oxidative stress levels, a hallmark of ALS neurons (reviewed in <xref ref-type="bibr" rid="ref11">Barber and Shaw, 2010</xref>), and they do so in the absence of glial cells, suggesting that a neuronal-autonomous/paracrine mechanism may contribute to the alteration of redox homeostasis in neurons displaying TDP-43 proteinopathy. Importantly, wtTDP-43 and mutTDP-43 neurons show a basal increase of ROS production, indicating a chronic oxidative condition; moreover, these neurons display a reduced ability to counteract a condition of iron overload, used here to mimic the signs of iron accumulation that have been detected in the motor cortex (<xref ref-type="bibr" rid="ref17">Bhattarai et al., 2020</xref>), frontal operculum, and precentral gyrus (<xref ref-type="bibr" rid="ref85">Mitani et al., 2021</xref>) of ALS patients. Iron overload may, in turn, affect not only the neuronal reducing potential, but also calcium homeostasis and synaptic function (<xref ref-type="bibr" rid="ref96">Pelizzoni et al., 2008</xref>). We found that several mRNAs relative to the oxidative stress response are underrepresented in the axon of wtTDP-43 and mutTDP-43 neurons; thus, it is reasonable to hypothesize that axonal translation may contribute importantly to the control of oxidative stress and that, in tract neurons projecting very long axons, this contribution may be extremely important; in fact axons account for &#x003E;95% of the total neuronal volume.</p>
<p>Among the downregulated axonal mRNAs, <italic>Prdx2</italic> is highly expressed in normal spinal motoneurons (<xref ref-type="bibr" rid="ref66">Kato et al., 2004</xref>) and plays an essential role in detoxifying hydrogen peroxide. Peroxiredoxins protect neurons from oxidative stress (<xref ref-type="bibr" rid="ref15">Bettegazzi et al., 2019</xref>) and their reduced level in ALS neuronal axons might therefore contribute to functional alterations of UMNs (<xref ref-type="bibr" rid="ref77">Liu et al., 2020</xref>). <italic>Prdx2</italic> is temporarily upregulated in the spinal cord of presymptomatic SOD1 mice (<xref ref-type="bibr" rid="ref98">Pharaoh et al., 2019</xref>) and in surviving ALS patients&#x2019; motoneurons at an intermediate disease stage, while at late stages the breakdown of this antioxidant system accelerates neuronal death (<xref ref-type="bibr" rid="ref65">Kato et al., 2005</xref>). Further studies are required to assess whether <italic>Prdx2</italic> plays a protective role in ALS/FTD neuronal models.</p>
<p>With respect to synaptic activity, repeated bursts of postsynaptic currents, which represent a typical electrical activity pattern scored in mature cortical neuron cultures, were sharply and significantly decreased in our human TDP-43-expressing populations, while burst duration only showed a nonsignificant decreasing trend.</p>
<p>Burst activity is often mediated by an increase of intracellular calcium (<xref ref-type="bibr" rid="ref59">Helmchen et al., 1999</xref>; <xref ref-type="bibr" rid="ref70">Larkum et al., 1999</xref>; <xref ref-type="bibr" rid="ref122">Williams and Stuart, 1999</xref>), and the decrease in burst frequency observed in wtTDP-43 and mutTDP-43 neurons is in keeping with the finding that [Ca<sup>2+</sup>]<sub>i</sub> is significantly reduced. Although several studies (<italic>inter alia</italic>, <xref ref-type="bibr" rid="ref97">Perkins et al., 2021</xref>) found an opposite condition in ALS models, a reduction of hyperexcitability to a condition of hypoexcitability has been observed in human iPSC-derived neurons during their aging in culture (<xref ref-type="bibr" rid="ref105">Sareen et al., 2013</xref>; <xref ref-type="bibr" rid="ref37">Devlin et al., 2015</xref>; <xref ref-type="bibr" rid="ref89">Naujock et al., 2016</xref>; <xref ref-type="bibr" rid="ref54">Guo et al., 2017</xref>; <xref ref-type="bibr" rid="ref90">Naumann et al., 2018</xref>; <xref ref-type="bibr" rid="ref110">Sommer et al., 2022</xref>). The homogeneous composition of the culture system reported here reveals features that are intrinsic to glutamatergic neurons, unaffected by the contribution of astrocytes. Moreover, this result is also in agreement with the deregulation of calcium ion homeostasis observed in different ALS models and proposed as a pathophysiological hallmark of the disease; indeed, in addition to an alteration of glutamate neurotransmission, several mechanisms involved in calcium handling (e.g., plasma membrane calcium extrusion, calcium influx through AMPA glutamate receptors, and calcium import from endoplasmic reticulum into mitochondria) have been found altered in ALS motor neurons (<xref ref-type="bibr" rid="ref53">Guatteo et al., 2007</xref>; <xref ref-type="bibr" rid="ref109">Sirabella et al., 2018</xref>). Importantly, an impairment of presynaptic vesicle dynamics has been described in human iPSC-derived cortical neurons and spinal motoneurons from ALS patients (<xref ref-type="bibr" rid="ref62">Jensen et al., 2020</xref>; <xref ref-type="bibr" rid="ref97">Perkins et al., 2021</xref>; <xref ref-type="bibr" rid="ref3">Aly et al., 2023</xref>). The significant decrease in exocytosis, revealed by FM1-43, is in agreement with the observation of reduced excitability, and may partially explain the disruption of connectivity observed in patients and animal models. Furthermore, the depletion of synaptic vesicles, revealed by EM, contributes to the global impairment of synaptic functions of human TDP-43-expressing neurons. Taken together, the decrease in PSC burst frequency in wtTDP-43 and mutTDP-43 cells was in accordance with reduced calcium responses and decreased vesicle availability at presynaptic terminals (which altogether may lower the probability of burst occurrence and synchronization across the synaptic network). The surprising observation that mEPSCs were unaffected may suggest that the probability of spontaneous, action potential-independent release of individual vesicles is less sensitive to the above mentioned changes, which likely influence massive events driven by strong presynaptic activation.</p>
<p>Our systems biology analysis shows that the levels of numerous polysome-engaged mRNAs encoding synaptic proteins is reduced both in the axon and cell body of human TDP-43-expressing neurons. Of note, a considerable number of downregulated transcripts involved in synaptic vesicle exocytosis (such as <italic>Rab3a</italic>, <italic>Stx5a</italic>, <italic>Stx16</italic>, <italic>Snap25</italic>, <italic>Munc13</italic>, <italic>Rims1</italic>, and <italic>Syt7</italic>), are selectively downregulated in the axonal compartment of wtTDP-43 neurons, in keeping with the observation that exocytosis is more severely impaired in neurons transduced with wt TDP-43. Indeed, the expression of mutant TDP-43 may cause a more global impairment, affecting neuronal maturation, supported by the significantly decreased number of synaptic vesicles scored in this population (<xref ref-type="fig" rid="fig5">Figure 5C</xref>&#x2032;). More broadly, the results of our translatome analysis indicate that wtTDP-43 expressing neurons display a selective impairment of axonal mRNA translation, whereas cells expressing mutTDP-43 exhibit changes that affect the cell body and axon alike. As pointed out in the introduction, cytoplasmic accumulation of wtTDP-43 and subsequent aggregate formation is a feature of nearly all cases of ALS, most of which do not stem from <italic>TARDBP</italic> mutation. Our results support the notion that wtTDP-43 deregulation is a causal factor, not just a bystander effect in ALS pathology.</p>
<p>Polysomal mRNAs deregulated in the axon of wtTDP-43 and mutTDP-43 neurons control various aspects of presynaptic function, including cell adhesion, synapse formation, calcium responses, vesicular lumen acidification, glutamate synthesis, and neurotransmitter release. Likewise, a possible impairment of endocytosis is suggested by the reduced levels of transcripts involved in this phase of vesicle trafficking (<xref ref-type="bibr" rid="ref34">Cremona et al., 1999</xref>; <xref ref-type="bibr" rid="ref80">Mani et al., 2007</xref>; <xref ref-type="bibr" rid="ref84">Miller et al., 2015</xref>).</p>
<p>The findings described here leave a key question unanswered, namely whether translation downregulation is restricted to TDP-43-bound mRNAs, possibly increasing the overall translation capacity for TDP-43-unbound transcripts.</p>
</sec>
<sec sec-type="conclusions" id="sec10">
<title>Conclusion</title>
<p>This paper presents the results of multiple functional analyses performed on two cellular models of TDP-43 proteinopathy, the commonest neuropathological hallmark of ALS. The changes observed in our study correlate with a deregulation of axonal translation, further supporting its importance in the context of numerous homeostatic and functional processes. In particular, the prompt availability of proteins that are localized to the axon via slow axonal transport (<xref ref-type="bibr" rid="ref103">Roy, 2020</xref>) may be critically dependent on local mRNA translation. This, among other factors, may account for the high sensitivity of long-range projection neurons to ALS.</p>
</sec>
<sec sec-type="methods" id="sec11">
<title>Methods</title>
<sec id="sec12">
<title>Primary culture of cortical neurons</title>
<p>Animal handling and experimental procedures were performed in accordance with the EC guidelines (EC Council Directive 86/6091987) and with the Italian legislation on animal experimentation (Decreto L.vo 116/92) and approved by our Institutional Animal Care and Use Committee.</p>
<p>Mouse embryonic cerebral cortices (strain C57BL/6&#x2009;N) were harvested at gestational day 14.5 (E14.5) and digested with Trypsin (Gibco, 15090-046). To obtain a single cell suspension the cells were mechanically dissociated with a glass Pasteur in neuronal culture medium (Neurobasal&#x2122; Plus Medium, Gibco A3582901, 1X B-27&#x2122; Plus Supplement, Gibco, A35828-01); the cell concentration was calculated with the T20 automated Cell Counter (Biorad). Cortical neurons were plated at the density of 42,000/cm<sup>2</sup> on plastic or glass slides treated with Poly-D-Lysine (100&#x2009;&#x03BC;g/mL, Sigma, P6407), and cultured in an incubator at 37&#x00B0;C, 5% CO2. For specific experiments, cortical neurons were plated on microfluidic chambers (Xona Microfluidics, SND-450). In the cell body compartment, more neuron culture medium volume was added relative to the axonal compartment to generate hydrostatic pressure. At 2&#x2009;days <italic>in vitro</italic> (DIV) 20&#x2009;ng/mL BDNF (Proteintech, 450-02-B) was added to the axonal compartment; fresh BDNF (20&#x2009;ng/mL) was added every 3 days.</p>
</sec>
<sec id="sec13">
<title>Generation of lentiviruses expressing TDP-43 (wt and A315T)</title>
<p>For overexpression experiments in cortical neurons, we generated constructs encoding the human wt TDP-43 (wtTDP-43) and the human mutant TDP-43 (mutTDP-43), fused N-terminally with the turbo-Red Fluorescent Protein or the FLAG tag (DYKDDDDK, <xref ref-type="bibr" rid="ref41">Einhauer and Jungbauer, 2001</xref>); the turbo-Red Fluorescent Protein (tRFP) was used as a control. For calcium assays control neurons were transduced with empty vector p277 instead of tRFP due to technical issues with the imaging instrument. The vectors were engineered in the laboratory, starting from the lentiviral vector pLenti277-GFP kindly provided by L. Naldini (San Raffaele-Telethon Institute of Gene Therapy, Milan, Italy). Lentiviral particles were prepared as described previously (<xref ref-type="bibr" rid="ref5">Amendola et al., 2005</xref>). Briefly HEK293T cells were transiently co-transfected using the calcium-phosphate precipitation method with the transfer vectors, the MDLg/pRRE plasmid, the RSV-Rev plasmid and the MDLg plasmid encoding the G glycoprotein of the vesicular stomatitis virus. Cell supernatants containing lentiviral particles were collected 72&#x2009;h after transfection, filtered and subjected to ultracentrifugation. The pellets were resuspended, divided into aliquots and stored at &#x2212;80&#x00B0;C. To calculate the titer of lentiviral particles, cortical neurons were seeded in a 24-well plate and infected at 5 DIV with serial dilutions (10<sup>&#x2212;3</sup> to 10<sup>&#x2212;7</sup>) of lentiviral particles overexpressing tRFP-TDP-43(wt), tRFP-TDP-43(A315T) and tRFP. Uninfected cortical neurons were used as controls. The experiment was repeated in triplicate for each condition. Cortical neurons were fixed after 9&#x2009;days <italic>in vitro</italic> (DIV) and processed for immunofluorescence with tRFP and TuJ1 primary antibodies. ArrayScan microscope (Thermo Fisher ArrayScan XTI HCA Reader) was used to acquire 20 random fields/well. For every field we counted tRFP-positive infected cells (red) and the total number of cells, stained with a nuclear marker (DAPI). A ratio of total tRFP-positive cells to DAPI-positive cells was calculated for each well. To calculate the titer a given ratio of tRFP-positive cells to total DAPI positive cells between 0.1% and 10% (dynamic range) was chosen, and this formula was used: (Infected cells/Total cells) &#x002A;Dilution factor &#x002A;Number of seeded cells. In our experiments a multiplicity of infection (MOI)&#x2009;=&#x2009;4 was used to achieve the transduction of most cells (average&#x2009;&#x003E;&#x2009;96%, see <xref ref-type="fig" rid="fig1">Figure 1A&#x2032;</xref>), without detectable cellular toxicity. Cortical neurons were infected at 5 DIV and treated, fixed or lysed at different DIV based on the experimental needs.</p>
</sec>
<sec id="sec14">
<title>Immunofluorescence</title>
<p>Cells were fixed with 4% Paraformaldehyde (PFA)/4% Sucrose in 1X PBS for 15&#x2009;min, then incubated with primary antibodies in 10% Goat Serum (GS), 0.1% Triton in 1X PBS overnight at 4&#x00B0;C. For antibodies directed against nuclear epitopes a permeabilization step of 10&#x2009;min with 0.5% Triton in 1X PBS was added. Subsequently, cells were incubated with secondary antibodies, washed three times with 1X PBS and counterstained with DAPI (D9542, Sigma). Images were acquired using Leica Confocal SP8 (Leica TCS SP8 SMD FLIM Laser canning Confocal), Nikon Spinning Disk (Nikon CSU-X1 Spinning Disk, Nikon TE2 inverted microscope), Axio Observer (Zeiss Axio Observer.Z1 with Hamamatsu EM9100). The quantification of all experiments was performed with the NIS-element Software (Nikon). When IF analyses were combined with heat shock treatments, cortical neurons were seeded in 24-well plates and infected as usual. At 14 DIV the plates were incubated in a water bath at 43&#x00B0;C for 60&#x2009;min, washed in 1X D-PBS and processed for immunofluorescence.</p>
</sec>
<sec id="sec15">
<title>Western blotting</title>
<p>Cortical neurons were scraped at room temperature using 50&#x2009;&#x03BC;L of Lysis Buffer (5% SDS, 10&#x2009;mM EDTA, 50&#x2009;mM Hepes pH 7.4) with the addition of protease inhibitors (Leupeptin, Sigma, L2884; Aprotinin, Sigma, A1153; PMSF, Sigma, P7626; Pepstatin A, Sigma, P5318; Sodium Orthovanadate, Sigma, S6508; Sodium Pyrophosphate, Sigma, 221,368; Sodium Fluoride Sigma, S6776; &#x03B2;-Glycerophosphate Sigma, G6251). All protein extracts were sonicated and quantified with Pierce &#x2122; BCA Protein Assay kit (ThermoFisher, 23225). 25&#x2009;&#x03BC;g protein lysate were resuspended in Laemmli buffer 1X (Sigma, S3401-1VL), denatured at 95&#x00B0;C for 5&#x2009;min and loaded onto a polyacrylamide gel (Mini-PROTEAN(R) TGX &#x2122; Precast Gels 4%&#x2013;20%, Biorad, 456-1094). Proteins were transferred to a nitrocellulose membrane (Biorad, 1704,159) using Trans-Blot(R) Turbo&#x2122; (Biorad). Membranes were incubated in blocking buffer (5% milk in TTBS) for 1&#x2009;h at RT, then overnight at 4&#x00B0;C with primary antibodies diluted in blocking buffer. The membranes were incubated with secondary antibodies in blocking buffer. Bands were revealed using the Clarity &#x2122; Western ECL Substrate (Biorad, 170-5061). The images were acquired using the ChemiDoc&#x2122;MP (Biorad) and the quantification was performed with Image Lab &#x2122;Software (Biorad).</p>
</sec>
<sec id="sec16">
<title>Primary and secondary antibodies</title>
<p>See <xref rid="SM1" ref-type="supplementary-material">Supplemental Table 2</xref>.</p>
</sec>
<sec id="sec17">
<title>Subcellular fractionation</title>
<p>All described procedures were performed at 4&#x00B0;C. Cortical neurons were washed in 1xPBS, scraped and lysed for 10&#x2009;min in Lysis Buffer (50&#x2009;mM Tris&#x2013;HCl pH 8.0, 10&#x2009;mM NaCl, 5&#x2009;mM MgCl2, 0.1% Nonidet P-40) with the addition of protease inhibitors. The lysate was spun at 1,000 &#x00D7; g for 15&#x2009;min to pellet the nuclear fraction (P1). The supernatant (S1) was centrifuged at 50.000&#x2009;rpm for 60&#x2009;min in a TLA55 rotor (Beckman) to yield crude cytosol (S2) and crude membrane pellet (P2). The pellet (P2) was resuspended in Lysis buffer without Nonidet P-40 and centrifuged again at 50.000&#x2009;rpm for 60&#x2009;min to yield washed crude membrane pellet (P2&#x2019;). The nuclear fraction (P1) was washed three times with Lysis buffer without Nonidet P-40 at 1,000 &#x00D7; g for 15&#x2009;min. Pellet was resuspended in a high-salt buffer (20&#x2009;mM HEPES pH 7.5, 0.5&#x2009;M NaCl, 1&#x2009;mM EDTA, 1&#x2009;mM dithiothreitol and protease inhibitors) and rotated for 20&#x2009;min. The pellet was centrifuged at 17.700&#x2009;g for 30&#x2009;min and the supernatant, containing the nuclear extract, was collected.</p>
</sec>
<sec id="sec18">
<title>Puromycylation assay</title>
<p>DIV 14 cortical neurons plated on microfluidic chambers were treated with 2&#x2009;&#x03BC;M puromycin (Sigma, P8833) for 5&#x2009;min. Pulse-labeling with a low concentration of puromycin, a structural analog of aminoacyl-tRNAs that is incorporated by nascent polypeptide chains, causing peptide release and disassembly of the two ribosomal subunits, was used as a readout of new protein synthesis (<xref ref-type="bibr" rid="ref35">David et al., 2012</xref>). After treatment, the cultures were fixed and processed for immunofluorescence using an anti-puromycin primary antibody. Puromycin mean pixel intensity was measured in the soma, in 30&#x2009;&#x03BC;m axon shaft and in the growth cone of at least 10 neurons per condition for each experiment.</p>
</sec>
<sec id="sec19">
<title>Colocalization analysis</title>
<p>Colocalization analysis between tRFP-tagged TDP43 and endogenous HuC/D, RPS6 and RPL26 was performed in the soma of DIV 9 cortical neurons, at least 10 neurons per condition for each experiment. Pearson&#x2019;s correlation analysis was carried out using the ImageJ plugin JACoP; thresholds were set as described (<xref ref-type="bibr" rid="ref19">Bolte and Cordelieres, 2006</xref>).</p>
</sec>
<sec id="sec20">
<title>ROS measurement</title>
<p>Cortical neurons, plated in a 96-well plate (Greiner Bio-One, 655090) and cultured up to DIV 13, were loaded with 5&#x2009;&#x03BC;M dichlorofluorescein diacetate (CM-H2DCFDA, Thermofisher, C6827), a probe that turns into a fluorescent molecule (2&#x2032;,7&#x2032;-dichlorofluorescein, DCF) upon oxidation by intracellular ROS. The CM-H2DCFDA loading was performed in KRH pH 7.4 buffer (125&#x2009;mM NaCl, 25&#x2009;mM Hepes/NaOH pH 7.4, 5&#x2009;mM KCl, 1.2&#x2009;mM MgCl2, 2&#x2009;mM CaCl2, 6&#x2009;mM Glucose) for 30&#x2009;min at 37&#x00B0;C, followed by 10&#x2009;min of incubation with the nuclear dye 1X Hoechst (Sigma, 33258; <xref ref-type="bibr" rid="ref118">Vannocci et al., 2018</xref>). For iron overload, neurons were treated with 20&#x2009;&#x03BC;M ferric ammonium citrate for 2&#x2009;days before the analysis (<xref ref-type="bibr" rid="ref27">Codazzi et al., 2016</xref>). The images were acquired using ArrayScan (ThermoFisher ArrayScan XTI HCA Reader) and the fluorescence intensity analysis was carried out by the ALEMBIC Facility of the San Raffaele Hospital.</p>
</sec>
<sec id="sec21">
<title>Electrophysiology</title>
<p>Individual slides with cortical neuronal cultures were placed in a recording chamber mounted on the stage of an upright BX51WI microscope (Olympus) equipped with differential interference contrast optics (DIC). Cultures were perfused with artificial cerebrospinal fluid (ACSF) containing (in mM): 125 NaCl, 2.5 KCl, 1.25 NaH<sub>2</sub>PO<sub>4</sub>, 2 CaCl<sub>2</sub>, 25 NaHCO<sub>3</sub>, 1 MgCl<sub>2</sub>, and 11 D-glucose, saturated with 95% O<sub>2</sub> and 5% CO<sub>2</sub> (pH 7.3). ACSF was continuously flowing at a rate of 2&#x2013;3&#x2009;mL/min at 32&#x00B0;C. For mEPSC recordings, ACSF was added with the Na&#x2009;+&#x2009;channel specific blocker tetrodotoxin (TTX, 1&#x2009;&#x03BC;M). Whole-cell patch-clamp recordings were performed in cortical neurons using pipettes filled with a solution containing the following (in mM): 124 KH<sub>2</sub>PO<sub>4</sub>, 10 NaCl, 10 HEPES, 0.5 EGTA, 2 MgCl<sub>2</sub>, 2 Na2-ATP, 0.02 Na-GTP (pH 7.2, adjusted with KOH; tip resistance: 4&#x2013;6&#x2009;M&#x03A9;). All recordings were performed using a MultiClamp 700B amplifier interfaced with a computer through a Digidata 1440A (Molecular Devices, Sunnyvale, CA, United States). Traces were sampled at a frequency of 10&#x2009;kHz and low pass filtered at 2&#x2009;kHz. Data were acquired using Clampex software (Molecular Devices) and analyzed with Clampfit and GraphPad Prism applications. Statistical comparisons were obtained using SigmaStat 3.5 (Systat, San Jose, CA).</p>
</sec>
<sec id="sec22">
<title>Calcium analyses</title>
<p>Cortical neurons were incubated with 4&#x2009;&#x03BC;M fura-2 acetoxymethyl ester (AM, Calbiochem, CAS 108964-32-5) 40&#x2009;min at 37&#x00B0;C; the ratiometric properties of fura-2 (excitation at 340&#x2009;nm and 380&#x2009;nm and emission at 510&#x2009;nm) permit the analysis of intracellular Ca2+ levels both at basal conditions and upon stimulation with 100&#x2009;&#x03BC;M glutamate. Imaging setup and analysis are the same of FM1-43 assay. Single-cell video imaging setup consists of an Axioskope 2 microscope (Zeiss, Oberkochen, Germany) and a Polychrome IV (Till Photonics, GmbH, Martinsried, Germany) light source. Fluorescence images were collected by a cooled CCD video camera (PCO Computer Optics GmbH, Kelheim, Germany), with a rate of 1 ratio image every 2&#x2009;s. The &#x201C;Vision&#x201D; software (Till Photonics) was used to control the acquisition protocol and to perform data analysis (<xref ref-type="bibr" rid="ref26">Codazzi et al., 2006</xref>; <xref ref-type="bibr" rid="ref102">Rosato et al., 2022</xref>).</p>
</sec>
<sec id="sec23">
<title>FM1-43 assay</title>
<p>Neurons were loaded with fura-2&#x2009;AM as previously described, before being subjected to the FM1-43 assay. FM1-43 is a styryl dye whose loading and release from synaptic vesicles provides a reliable measurement of vesicle release. The neurons were treated with 20&#x2009;&#x03BC;M FM1-43 (Sigma, cat. SCT126; <xref ref-type="bibr" rid="ref16">Betz and Bewick, 1992</xref>), dissolved in high K+ (60&#x2009;mM)-containing KRH (HK-KRH; Na+&#x2009;concentration was adjusted to maintain isotonicity), diluted 1:1 in normal KRH to obtain the required final KCl and FM1-43 concentration (30&#x2009;mM and 10&#x2009;&#x03BC;M respectively). FM1-43 was kept in the extracellular solution for 2&#x2009;min, to complete endocytosis; this step was followed by several washes with dye-free KRH buffer, to eliminate the excess of FM1-43; after an additional stimulation with HK-KRH, fluorescence decay of FM1-43 over time was measured. The imaging setup is the same described for fura-2 calcium assay. FM1-43 fluorescence analyses were performed as described (<xref ref-type="bibr" rid="ref71">Lazarenko et al., 2018</xref>).</p>
</sec>
<sec id="sec24">
<title>Electron microscopy analysis</title>
<p>Neuronal cultures were fixed with 4% paraformaldehyde (PFA) and 2% (wt/vol.) glutaraldehyde in cacodylate buffer 0.12&#x2009;moL/L pH 7.4 overnight at 4&#x00B0;C, followed by incubation at room temperature for 2&#x2009;h in 1% (wt/vol.) OsO4, 1.5% potassium ferrocyanide in 100&#x2009;mM cacodylate buffer pH 7.4 for 1&#x2009;h on ice. After dehydration in a graded series of ethanol preparations, tissue samples were cleared in propylene oxide, embedded in epoxy medium (Epoxy Embedding Medium kit; Sigma-Aldrich, St. Louis, MO 63103 USA), and polymerized at 60&#x00B0;C for 72&#x2009;h. From each sample, one semi-thin (1&#x2009;&#x03BC;m) section was cut with a Leica EM UC6 ultramicrotome (Leica Microsystems, Vienna, Austria). Ultra-thin (60&#x2009;nm thick) sections of areas of interest were then obtained, counterstained with uranyl acetate and lead citrate, and examined with a transmission electron microscope (Talos 120C Fei), image were acquired with a 4kx4k Ceta CMOS camera (Thermo Fisher Scientific).</p>
</sec>
<sec id="sec25">
<title>Transcriptome and translatome analysis</title>
<p>Miniaturized sucrose gradients were used to isolate free or polysomal RNA from cell bodies and axons of CNs cultured in microfluidic chambers, as described above. The procedure for polysome profiling by miniaturized sucrose gradient fractionation was adapted from published protocols (<xref ref-type="bibr" rid="ref91">Negro et al., 2018</xref>). The procedure consists of the following steps: (i) wtTDP-43, mutTDP-43 and ctr neurons are plated in microfluidic chambers for 9 DIV; (ii) axonal and cell body compartments of these neurons are lysed and loaded onto a miniaturized sucrose gradient to separate polysome-engaged mRNAs from sub-polysomal mRNAs; (iii) polysomal mRNAs and sub-polysomal mRNA fractions are isolated; (iv) mRNAs are extracted from these fractions and sequenced (see also <xref rid="SM1" ref-type="supplementary-material">Supplementary Figure 5</xref>).</p>
<p>Sequencing data were retrieved from Gene Expression Omnibus (GEO ID: GSE239419) and processed as described by the authors. Briefly, reads were first preprocessed for adapter removal and trimming, then mapped to the mouse genome (GRCm38.p6, ENSEMBL release 92 and Gencode M17 gene annotation) and finally deduplicated. After sample size normalization based on the trimmed mean of M-values method, only genes with FPKM &#x003E; 10 in all replicates of at least 1 sample were kept for subsequent analysis. Differentially expressed genes were identified by the edgeR applying multiple thresholds (CPM&#x2009;&#x003E;&#x2009;0.05, absolute log2 fold change &#x003E; 0.75, value of <italic>p</italic> &#x003C; 0.05). Annotation enrichment analysis with Gene Ontology terms, REACTOME and KEGG pathways were performed with the clusterProfiler Bioconductor package. GO analysis was performed as described (<xref ref-type="bibr" rid="ref14">Bernabo et al., 2017</xref>).</p>
<p>Gene ontology tables were searched using the following query words: translation, ribosom&#x002A; and polysom&#x002A; for mRNA translation; oxidative, peroxid&#x002A; and reactive oxygen species for oxidative stress; synap&#x002A;; vesicle, exocyt&#x002A;, endocyt&#x002A; and neurotransmitter for synaptogenesis and synaptic function.</p>
</sec>
<sec id="sec26">
<title>Statistical analysis</title>
<p>All values are expressed as mean&#x2009;&#x00B1;&#x2009;standard error of the mean (SEM) of at least 3 independent experiments. Statistical analysis was performed using the GraphPad Prism software for the choice of optimal statistical tests based on data distribution. The statistical tests for each experiment are reported in the figure legends. Differences yielding a <italic>p</italic> value &#x2265; 0.05 were regarded as non-significant. With respect to decay curves (<xref ref-type="fig" rid="fig5">Figure 5</xref>), we fitted the model <inline-formula><mml:math id="M1"><mml:mi mathvariant="italic">fluorescence</mml:mi><mml:mo>=</mml:mo><mml:msup><mml:mn>2</mml:mn><mml:mrow><mml:mfenced open="(" close=")"><mml:mrow><mml:msub><mml:mi>&#x03B1;</mml:mi><mml:mrow><mml:mi>c</mml:mi><mml:mi>t</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mo stretchy="true">&#x2211;</mml:mo><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:msub><mml:mi mathvariant="normal">&#x0394;</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:mfenced><mml:mi>t</mml:mi></mml:mrow></mml:msup><mml:mi>&#x03B5;</mml:mi></mml:math></inline-formula>where &#x03B1;<sub><italic>ctr</italic></sub> is the coefficient for the controls; <italic>I</italic><sub><italic>i</italic></sub> is the indicatrix functions for experimental condition and &#x2206;<italic>i</italic> represents the difference between control and the experimental condition <italic>i. &#x03B5;</italic> is supposed to have lognormal distribution.This model allows an easy interpretation of fluorescence decay because &#x03B1;<sub><italic>ctr</italic></sub>, (&#x03B1;<sub><italic>ctr</italic></sub>+&#x2206;<sub><italic>hTDP</italic>-43</sub>) and (&#x03B1;<sub><italic>ctr</italic></sub>+&#x2206;<sub><italic>mutTDP</italic>-43</sub>) are related to the fluorescence half-life in the three experimental conditions. Furthermore, multiplicative log-normal distributed errors address for the higher variability observed in correspondence of higher mean values.</p>
</sec>
</sec>
<sec sec-type="data-availability" id="sec27">
<title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec sec-type="ethics-statement" id="sec28">
<title>Ethics statement</title>
<p>The animal study was approved by: Il Comitato I.A.C.U.C.&#x2014;Ospedale San Raffaele, Organismo Preposto al Benessere degli Animali. The study was conducted in accordance with the local legislation and institutional requirements.</p>
</sec>
<sec sec-type="author-contributions" id="sec29">
<title>Author contributions</title>
<p>AP: Conceptualization, Data curation, Investigation, Methodology, Writing &#x2013; original draft. LC: Conceptualization, Data curation, Investigation, Methodology, Writing &#x2013; original draft, Formal analysis, Supervision, Validation. FL: Data curation, Formal analysis, Investigation, Methodology, Visualization, Writing &#x2013; review &#x0026; editing. CM: Data curation, Investigation, Methodology, Visualization, Writing &#x2013; review &#x0026; editing. ES: Investigation, Methodology, Visualization, Writing &#x2013; review &#x0026; editing. AA: Data curation, Software, Visualization, Writing &#x2013; review &#x0026; editing. PP: Investigation, Methodology, Visualization, Writing &#x2013; review &#x0026; editing. MM: Investigation, Methodology, Visualization, Writing &#x2013; review &#x0026; editing. FiC: Visualization, Writing &#x2013; review &#x0026; editing. OC: Writing &#x2013; review &#x0026; editing. ST: Writing &#x2013; review &#x0026; editing, Investigation, Methodology, Writing &#x2013; original draft. AQ: Investigation, Methodology, Data curation, Visualization, Writing &#x2013; review &#x0026; editing. J-MC: Investigation, Methodology, Conceptualization, Visualization, Writing &#x2013; review &#x0026; editing. GV: Data curation, Methodology, Funding acquisition, Investigation, Visualization, Writing &#x2013; review &#x0026; editing. FrC: Data curation, Funding acquisition, Investigation, Methodology, Writing &#x2013; review &#x0026; editing, Conceptualization, Formal analysis, Supervision, Validation, Visualization, Writing &#x2013; original draft. GC: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Resources, Software, Supervision, Validation, Validation, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing.</p>
</sec>
</body>
<back>
<sec sec-type="funding-information" id="sec30">
<title>Funding</title>
<p>This study has been supported by AriSLA (AxRibALS grant to GC and GV) and Ministero della Salute (RF21-2766 to FrC and GC). J-MC and ES are funded by the European Union (ERC Starting Grant, AXONENDO, 851966).</p>
</sec>
<ack>
<p>The authors thank all members of the GC and GV labs for critical discussion of our data. Thanks to Claudia Rivoletti for preliminary experiments. AP was supported during her PhD studies thanks to a very generous donation by the Fronzaroli family. Image analysis was carried out at ALEMBIC, an advanced microscopy laboratory established by the San Raffaele Scientific Institute and University.</p>
</ack>
<sec sec-type="COI-statement" id="sec31">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="sec100" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec sec-type="supplementary-material" id="sec32">
<title>Supplementary material</title>
<p>The Supplementary material for this article can be found online at: <ext-link xlink:href="https://www.frontiersin.org/articles/10.3389/fncel.2023.1253543/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fncel.2023.1253543/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Data_Sheet_1.docx" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="ref1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alami</surname> <given-names>N. H.</given-names></name> <name><surname>Smith</surname> <given-names>R. B.</given-names></name> <name><surname>Carrasco</surname> <given-names>M. A.</given-names></name> <name><surname>Williams</surname> <given-names>L. A.</given-names></name> <name><surname>Winborn</surname> <given-names>C. S.</given-names></name> <name><surname>Han</surname> <given-names>S. S.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations</article-title>. <source>Neuron</source> <volume>81</volume>, <fpage>536</fpage>&#x2013;<lpage>543</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neuron.2013.12.018</pub-id></citation></ref>
<ref id="ref2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Altman</surname> <given-names>T.</given-names></name> <name><surname>Ionescu</surname> <given-names>A.</given-names></name> <name><surname>Ibraheem</surname> <given-names>A.</given-names></name> <name><surname>Priesmann</surname> <given-names>D.</given-names></name> <name><surname>Gradus-Pery</surname> <given-names>T.</given-names></name> <name><surname>Farberov</surname> <given-names>L.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Axonal TDP-43 condensates drive neuromuscular junction disruption through inhibition of local synthesis of nuclear encoded mitochondrial proteins</article-title>. <source>Nat. Commun.</source> <volume>12</volume>:<fpage>6914</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-021-27221-8</pub-id></citation></ref>
<ref id="ref3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aly</surname> <given-names>A.</given-names></name> <name><surname>Laszlo</surname> <given-names>Z. I.</given-names></name> <name><surname>Rajkumar</surname> <given-names>S.</given-names></name> <name><surname>Demir</surname> <given-names>T.</given-names></name> <name><surname>Hindley</surname> <given-names>N.</given-names></name> <name><surname>Lamont</surname> <given-names>D. J.</given-names></name> <etal/></person-group>. (<year>2023</year>). <article-title>Integrative proteomics highlight presynaptic alterations and c-Jun misactivation as convergent pathomechanisms in ALS</article-title>. <source>Acta Neuropathol.</source> <volume>146</volume>, <fpage>451</fpage>&#x2013;<lpage>475</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00401-023-02611-y</pub-id></citation></ref>
<ref id="ref4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Amaral</surname> <given-names>E.</given-names></name> <name><surname>Guatimosim</surname> <given-names>S.</given-names></name> <name><surname>Guatimosim</surname> <given-names>C.</given-names></name></person-group> (<year>2011</year>). <article-title>Using the fluorescent styryl dye FM1-43 to visualize synaptic vesicles exocytosis and endocytosis in motor nerve terminals</article-title>. <source>Methods Mol. Biol.</source> <volume>689</volume>, <fpage>137</fpage>&#x2013;<lpage>148</lpage>. doi: <pub-id pub-id-type="doi">10.1007/978-1-60761-950-5_8</pub-id></citation></ref>
<ref id="ref5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Amendola</surname> <given-names>M.</given-names></name> <name><surname>Venneri</surname> <given-names>M. A.</given-names></name> <name><surname>Biffi</surname> <given-names>A.</given-names></name> <name><surname>Vigna</surname> <given-names>E.</given-names></name> <name><surname>Naldini</surname> <given-names>L.</given-names></name></person-group> (<year>2005</year>). <article-title>Coordinate dual-gene transgenesis by lentiviral vectors carrying synthetic bidirectional promoters</article-title>. <source>Nat. Biotechnol.</source> <volume>23</volume>, <fpage>108</fpage>&#x2013;<lpage>116</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nbt1049</pub-id></citation></ref>
<ref id="ref6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arai</surname> <given-names>T.</given-names></name> <name><surname>Hasegawa</surname> <given-names>M.</given-names></name> <name><surname>Akiyama</surname> <given-names>H.</given-names></name> <name><surname>Ikeda</surname> <given-names>K.</given-names></name> <name><surname>Nonaka</surname> <given-names>T.</given-names></name> <name><surname>Mori</surname> <given-names>H.</given-names></name> <etal/></person-group>. (<year>2006</year>). <article-title>TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis</article-title>. <source>Biochem. Biophys. Res. Commun.</source> <volume>351</volume>, <fpage>602</fpage>&#x2013;<lpage>611</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bbrc.2006.10.093</pub-id></citation></ref>
<ref id="ref7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Avendano-Vazquez</surname> <given-names>S. E.</given-names></name> <name><surname>Dhir</surname> <given-names>A.</given-names></name> <name><surname>Bembich</surname> <given-names>S.</given-names></name> <name><surname>Buratti</surname> <given-names>E.</given-names></name> <name><surname>Proudfoot</surname> <given-names>N.</given-names></name> <name><surname>Baralle</surname> <given-names>F. E.</given-names></name></person-group> (<year>2012</year>). <article-title>Autoregulation of TDP-43 mRNA levels involves interplay between transcription, splicing, and alternative polyA site selection</article-title>. <source>Genes Dev.</source> <volume>26</volume>, <fpage>1679</fpage>&#x2013;<lpage>1684</lpage>. doi: <pub-id pub-id-type="doi">10.1101/gad.194829.112</pub-id></citation></ref>
<ref id="ref8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ayala</surname> <given-names>Y. M.</given-names></name> <name><surname>De Conti</surname> <given-names>L.</given-names></name> <name><surname>Avendano-Vazquez</surname> <given-names>S. E.</given-names></name> <name><surname>Dhir</surname> <given-names>A.</given-names></name> <name><surname>Romano</surname> <given-names>M.</given-names></name> <name><surname>D'Ambrogio</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title>TDP-43 regulates its mRNA levels through a negative feedback loop</article-title>. <source>EMBO J.</source> <volume>30</volume>, <fpage>277</fpage>&#x2013;<lpage>288</lpage>. doi: <pub-id pub-id-type="doi">10.1038/emboj.2010.310</pub-id></citation></ref>
<ref id="ref9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ayala</surname> <given-names>Y. M.</given-names></name> <name><surname>Pantano</surname> <given-names>S.</given-names></name> <name><surname>D'Ambrogio</surname> <given-names>A.</given-names></name> <name><surname>Buratti</surname> <given-names>E.</given-names></name> <name><surname>Brindisi</surname> <given-names>A.</given-names></name> <name><surname>Marchetti</surname> <given-names>C.</given-names></name> <etal/></person-group>. (<year>2005</year>). <article-title>Human, drosophila, and C.Elegans TDP43: nucleic acid binding properties and splicing regulatory function</article-title>. <source>J. Mol. Biol.</source> <volume>348</volume>, <fpage>575</fpage>&#x2013;<lpage>588</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jmb.2005.02.038</pub-id></citation></ref>
<ref id="ref10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ayala</surname> <given-names>Y. M.</given-names></name> <name><surname>Zago</surname> <given-names>P.</given-names></name> <name><surname>D'Ambrogio</surname> <given-names>A.</given-names></name> <name><surname>Xu</surname> <given-names>Y. F.</given-names></name> <name><surname>Petrucelli</surname> <given-names>L.</given-names></name> <name><surname>Buratti</surname> <given-names>E.</given-names></name> <etal/></person-group>. (<year>2008</year>). <article-title>Structural determinants of the cellular localization and shuttling of TDP-43</article-title>. <source>J. Cell Sci.</source> <volume>121</volume>, <fpage>3778</fpage>&#x2013;<lpage>3785</lpage>. doi: <pub-id pub-id-type="doi">10.1242/jcs.038950</pub-id></citation></ref>
<ref id="ref11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barber</surname> <given-names>S. C.</given-names></name> <name><surname>Shaw</surname> <given-names>P. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Oxidative stress in ALS: key role in motor neuron injury and therapeutic target</article-title>. <source>Free Radic. Biol. Med.</source> <volume>48</volume>, <fpage>629</fpage>&#x2013;<lpage>641</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2009.11.018</pub-id></citation></ref>
<ref id="ref12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bedogni</surname> <given-names>F.</given-names></name> <name><surname>Hodge</surname> <given-names>R. D.</given-names></name> <name><surname>Elsen</surname> <given-names>G. E.</given-names></name> <name><surname>Nelson</surname> <given-names>B. R.</given-names></name> <name><surname>Daza</surname> <given-names>R. A.</given-names></name> <name><surname>Beyer</surname> <given-names>R. P.</given-names></name> <etal/></person-group>. (<year>2010</year>). <article-title>Tbr1 regulates regional and laminar identity of postmitotic neurons in developing neocortex</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>107</volume>, <fpage>13129</fpage>&#x2013;<lpage>13134</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.1002285107</pub-id></citation></ref>
<ref id="ref13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beers</surname> <given-names>D. R.</given-names></name> <name><surname>Henkel</surname> <given-names>J. S.</given-names></name> <name><surname>Xiao</surname> <given-names>Q.</given-names></name> <name><surname>Zhao</surname> <given-names>W.</given-names></name> <name><surname>Wang</surname> <given-names>J.</given-names></name> <name><surname>Yen</surname> <given-names>A. A.</given-names></name> <etal/></person-group>. (<year>2006</year>). <article-title>Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>103</volume>, <fpage>16021</fpage>&#x2013;<lpage>16026</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.0607423103</pub-id></citation></ref>
<ref id="ref14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bernabo</surname> <given-names>P.</given-names></name> <name><surname>Tebaldi</surname> <given-names>T.</given-names></name> <name><surname>Groen</surname> <given-names>E. J. N.</given-names></name> <name><surname>Lane</surname> <given-names>F. M.</given-names></name> <name><surname>Perenthaler</surname> <given-names>E.</given-names></name> <name><surname>Mattedi</surname> <given-names>F.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>In vivo Translatome profiling in spinal muscular atrophy reveals a role for SMN protein in ribosome biology</article-title>. <source>Cell Rep.</source> <volume>21</volume>, <fpage>953</fpage>&#x2013;<lpage>965</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.celrep.2017.10.010</pub-id></citation></ref>
<ref id="ref15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bettegazzi</surname> <given-names>B.</given-names></name> <name><surname>Pelizzoni</surname> <given-names>I.</given-names></name> <name><surname>Salerno Scarzella</surname> <given-names>F.</given-names></name> <name><surname>Restelli</surname> <given-names>L. M.</given-names></name> <name><surname>Zacchetti</surname> <given-names>D.</given-names></name> <name><surname>Maltecca</surname> <given-names>F.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Upregulation of Peroxiredoxin 3 protects Afg3l2-KO cortical neurons in vitro from oxidative stress: a paradigm for neuronal cell survival under neurodegenerative conditions</article-title>. <source>Oxid. Med. Cell. Longev.</source> <volume>2019</volume>:<fpage>4721950</fpage>. doi: <pub-id pub-id-type="doi">10.1155/2019/4721950</pub-id></citation></ref>
<ref id="ref16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Betz</surname> <given-names>W. J.</given-names></name> <name><surname>Bewick</surname> <given-names>G. S.</given-names></name></person-group> (<year>1992</year>). <article-title>Optical analysis of synaptic vesicle recycling at the frog neuromuscular junction</article-title>. <source>Science</source> <volume>255</volume>, <fpage>200</fpage>&#x2013;<lpage>203</lpage>. doi: <pub-id pub-id-type="doi">10.1126/science.1553547</pub-id></citation></ref>
<ref id="ref17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bhattarai</surname> <given-names>A.</given-names></name> <name><surname>Chen</surname> <given-names>Z.</given-names></name> <name><surname>Ward</surname> <given-names>P. G. D.</given-names></name> <name><surname>Talman</surname> <given-names>P.</given-names></name> <name><surname>Mathers</surname> <given-names>S.</given-names></name> <name><surname>Phan</surname> <given-names>T. G.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Serial assessment of iron in the motor cortex in limb-onset amyotrophic lateral sclerosis using quantitative susceptibility mapping</article-title>. <source>Quant. Imaging Med. Surg.</source> <volume>10</volume>, <fpage>1465</fpage>&#x2013;<lpage>1476</lpage>. doi: <pub-id pub-id-type="doi">10.21037/qims-20-187</pub-id></citation></ref>
<ref id="ref18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Blair</surname> <given-names>I. P.</given-names></name> <name><surname>Williams</surname> <given-names>K. L.</given-names></name> <name><surname>Warraich</surname> <given-names>S. T.</given-names></name> <name><surname>Durnall</surname> <given-names>J. C.</given-names></name> <name><surname>Thoeng</surname> <given-names>A. D.</given-names></name> <name><surname>Manavis</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2010</year>). <article-title>FUS mutations in amyotrophic lateral sclerosis: clinical, pathological, neurophysiological and genetic analysis</article-title>. <source>J. Neurol. Neurosurg. Psychiatry</source> <volume>81</volume>, <fpage>639</fpage>&#x2013;<lpage>645</lpage>. doi: <pub-id pub-id-type="doi">10.1136/jnnp.2009.194399</pub-id></citation></ref>
<ref id="ref19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bolte</surname> <given-names>S.</given-names></name> <name><surname>Cordelieres</surname> <given-names>F. P.</given-names></name></person-group> (<year>2006</year>). <article-title>A guided tour into subcellular colocalization analysis in light microscopy</article-title>. <source>J. Microsc.</source> <volume>224</volume>, <fpage>213</fpage>&#x2013;<lpage>232</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1365-2818.2006.01706.x</pub-id></citation></ref>
<ref id="ref20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Briese</surname> <given-names>M.</given-names></name> <name><surname>Saal-Bauernschubert</surname> <given-names>L.</given-names></name> <name><surname>Luningschror</surname> <given-names>P.</given-names></name> <name><surname>Moradi</surname> <given-names>M.</given-names></name> <name><surname>Dombert</surname> <given-names>B.</given-names></name> <name><surname>Surrey</surname> <given-names>V.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Loss of Tdp-43 disrupts the axonal transcriptome of motoneurons accompanied by impaired axonal translation and mitochondria function</article-title>. <source>Acta Neuropathol. Commun.</source> <volume>8</volume>:<fpage>116</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s40478-020-00987-6</pub-id></citation></ref>
<ref id="ref21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname> <given-names>R. H.</given-names></name> <name><surname>Al-Chalabi</surname> <given-names>A.</given-names></name></person-group> (<year>2017</year>). <article-title>Amyotrophic lateral sclerosis</article-title>. <source>N. Engl. J. Med.</source> <volume>377</volume>:<fpage>1602</fpage>. doi: <pub-id pub-id-type="doi">10.1056/NEJMc1710379</pub-id></citation></ref>
<ref id="ref22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname> <given-names>A. L.</given-names></name> <name><surname>Wilkins</surname> <given-names>O. G.</given-names></name> <name><surname>Keuss</surname> <given-names>M. J.</given-names></name> <name><surname>Hill</surname> <given-names>S. E.</given-names></name> <name><surname>Zanovello</surname> <given-names>M.</given-names></name> <name><surname>Lee</surname> <given-names>W. C.</given-names></name> <etal/></person-group>. (<year>2022</year>). <article-title>TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A</article-title>. <source>Nature</source> <volume>603</volume>, <fpage>131</fpage>&#x2013;<lpage>137</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41586-022-04436-3</pub-id></citation></ref>
<ref id="ref23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Buratti</surname> <given-names>E.</given-names></name></person-group> (<year>2015</year>). <article-title>Functional significance of TDP-43 mutations in disease</article-title>. <source>Adv. Genet.</source> <volume>91</volume>, <fpage>1</fpage>&#x2013;<lpage>53</lpage>. doi: <pub-id pub-id-type="doi">10.1016/bs.adgen.2015.07.001</pub-id></citation></ref>
<ref id="ref24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Buratti</surname> <given-names>E.</given-names></name> <name><surname>Dork</surname> <given-names>T.</given-names></name> <name><surname>Zuccato</surname> <given-names>E.</given-names></name> <name><surname>Pagani</surname> <given-names>F.</given-names></name> <name><surname>Romano</surname> <given-names>M.</given-names></name> <name><surname>Baralle</surname> <given-names>F. E.</given-names></name></person-group> (<year>2001</year>). <article-title>Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping</article-title>. <source>EMBO J.</source> <volume>20</volume>, <fpage>1774</fpage>&#x2013;<lpage>1784</lpage>. doi: <pub-id pub-id-type="doi">10.1093/emboj/20.7.1774</pub-id></citation></ref>
<ref id="ref25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname> <given-names>J. F.</given-names></name> <name><surname>Majumder</surname> <given-names>P.</given-names></name> <name><surname>Chatterjee</surname> <given-names>B.</given-names></name> <name><surname>Huang</surname> <given-names>S. L.</given-names></name> <name><surname>Shen</surname> <given-names>C. J.</given-names></name></person-group> (<year>2019</year>). <article-title>TDP-43 regulates coupled dendritic mRNA transport-translation processes in co-operation with FMRP and Staufen1</article-title>. <source>Cell Rep.</source> <volume>29</volume>, <fpage>3118</fpage>&#x2013;<lpage>3133 e3116</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.celrep.2019.10.061</pub-id></citation></ref>
<ref id="ref26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Codazzi</surname> <given-names>F.</given-names></name> <name><surname>Di Cesare</surname> <given-names>A.</given-names></name> <name><surname>Chiulli</surname> <given-names>N.</given-names></name> <name><surname>Albanese</surname> <given-names>A.</given-names></name> <name><surname>Meyer</surname> <given-names>T.</given-names></name> <name><surname>Zacchetti</surname> <given-names>D.</given-names></name> <etal/></person-group>. (<year>2006</year>). <article-title>Synergistic control of protein kinase Cgamma activity by ionotropic and metabotropic glutamate receptor inputs in hippocampal neurons</article-title>. <source>J. Neurosci.</source> <volume>26</volume>, <fpage>3404</fpage>&#x2013;<lpage>3411</lpage>. doi: <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0478-06.2006</pub-id></citation></ref>
<ref id="ref27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Codazzi</surname> <given-names>F.</given-names></name> <name><surname>Hu</surname> <given-names>A.</given-names></name> <name><surname>Rai</surname> <given-names>M.</given-names></name> <name><surname>Donatello</surname> <given-names>S.</given-names></name> <name><surname>Salerno Scarzella</surname> <given-names>F.</given-names></name> <name><surname>Mangiameli</surname> <given-names>E.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Friedreich ataxia-induced pluripotent stem cell-derived neurons show a cellular phenotype that is corrected by a benzamide HDAC inhibitor</article-title>. <source>Hum. Mol. Genet.</source> <volume>25</volume>, <fpage>4847</fpage>&#x2013;<lpage>4855</lpage>. doi: <pub-id pub-id-type="doi">10.1093/hmg/ddw308</pub-id></citation></ref>
<ref id="ref28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname> <given-names>T. J.</given-names></name> <name><surname>Lee</surname> <given-names>V. M.</given-names></name> <name><surname>Trojanowski</surname> <given-names>J. Q.</given-names></name></person-group> (<year>2011</year>). <article-title>TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies</article-title>. <source>Trends Mol. Med.</source> <volume>17</volume>, <fpage>659</fpage>&#x2013;<lpage>667</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.molmed.2011.06.004</pub-id></citation></ref>
<ref id="ref29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Colombrita</surname> <given-names>C.</given-names></name> <name><surname>Onesto</surname> <given-names>E.</given-names></name> <name><surname>Megiorni</surname> <given-names>F.</given-names></name> <name><surname>Pizzuti</surname> <given-names>A.</given-names></name> <name><surname>Baralle</surname> <given-names>F. E.</given-names></name> <name><surname>Buratti</surname> <given-names>E.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>TDP-43 and FUS RNA-binding proteins bind distinct sets of cytoplasmic messenger RNAs and differently regulate their post-transcriptional fate in motoneuron-like cells</article-title>. <source>J. Biol. Chem.</source> <volume>287</volume>, <fpage>15635</fpage>&#x2013;<lpage>15647</lpage>. doi: <pub-id pub-id-type="doi">10.1074/jbc.M111.333450</pub-id></citation></ref>
<ref id="ref30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Colombrita</surname> <given-names>C.</given-names></name> <name><surname>Zennaro</surname> <given-names>E.</given-names></name> <name><surname>Fallini</surname> <given-names>C.</given-names></name> <name><surname>Weber</surname> <given-names>M.</given-names></name> <name><surname>Sommacal</surname> <given-names>A.</given-names></name> <name><surname>Buratti</surname> <given-names>E.</given-names></name> <etal/></person-group>. (<year>2009</year>). <article-title>TDP-43 is recruited to stress granules in conditions of oxidative insult</article-title>. <source>J. Neurochem.</source> <volume>111</volume>, <fpage>1051</fpage>&#x2013;<lpage>1061</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1471-4159.2009.06383.x</pub-id></citation></ref>
<ref id="ref31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Conicella</surname> <given-names>A. E.</given-names></name> <name><surname>Zerze</surname> <given-names>G. H.</given-names></name> <name><surname>Mittal</surname> <given-names>J.</given-names></name> <name><surname>Fawzi</surname> <given-names>N. L.</given-names></name></person-group> (<year>2016</year>). <article-title>ALS mutations disrupt phase separation mediated by alpha-helical structure in the TDP-43 low-complexity C-terminal domain</article-title>. <source>Structure</source> <volume>24</volume>, <fpage>1537</fpage>&#x2013;<lpage>1549</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.str.2016.07.007</pub-id></citation></ref>
<ref id="ref32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cosker</surname> <given-names>K. E.</given-names></name> <name><surname>Fenstermacher</surname> <given-names>S. J.</given-names></name> <name><surname>Pazyra-Murphy</surname> <given-names>M. F.</given-names></name> <name><surname>Elliott</surname> <given-names>H. L.</given-names></name> <name><surname>Segal</surname> <given-names>R. A.</given-names></name></person-group> (<year>2016</year>). <article-title>The RNA-binding protein SFPQ orchestrates an RNA regulon to promote axon viability</article-title>. <source>Nat. Neurosci.</source> <volume>19</volume>, <fpage>690</fpage>&#x2013;<lpage>696</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nn.4280</pub-id></citation></ref>
<ref id="ref33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Costessi</surname> <given-names>L.</given-names></name> <name><surname>Porro</surname> <given-names>F.</given-names></name> <name><surname>Iaconcig</surname> <given-names>A.</given-names></name> <name><surname>Muro</surname> <given-names>A. F.</given-names></name></person-group> (<year>2014</year>). <article-title>TDP-43 regulates beta-adducin (Add2) transcript stability</article-title>. <source>RNA Biol.</source> <volume>11</volume>, <fpage>1280</fpage>&#x2013;<lpage>1290</lpage>. doi: <pub-id pub-id-type="doi">10.1080/15476286.2014.996081</pub-id></citation></ref>
<ref id="ref34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cremona</surname> <given-names>O.</given-names></name> <name><surname>Di Paolo</surname> <given-names>G.</given-names></name> <name><surname>Wenk</surname> <given-names>M. R.</given-names></name> <name><surname>Luthi</surname> <given-names>A.</given-names></name> <name><surname>Kim</surname> <given-names>W. T.</given-names></name> <name><surname>Takei</surname> <given-names>K.</given-names></name> <etal/></person-group>. (<year>1999</year>). <article-title>Essential role of phosphoinositide metabolism in synaptic vesicle recycling</article-title>. <source>Cells</source> <volume>99</volume>, <fpage>179</fpage>&#x2013;<lpage>188</lpage>. doi: <pub-id pub-id-type="doi">10.1016/s0092-8674(00)81649-9</pub-id></citation></ref>
<ref id="ref35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>David</surname> <given-names>A.</given-names></name> <name><surname>Dolan</surname> <given-names>B.</given-names></name> <name><surname>Hickman</surname> <given-names>H.</given-names></name> <name><surname>Knowlton</surname> <given-names>J.</given-names></name> <name><surname>Clavarino</surname> <given-names>G.</given-names></name> <name><surname>Pierre</surname> <given-names>P.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>Nuclear translation visualized by ribosome-bound nascent chain puromycylation</article-title>. <source>J. Cell Biol.</source> <volume>197</volume>, <fpage>45</fpage>&#x2013;<lpage>57</lpage>. doi: <pub-id pub-id-type="doi">10.1083/jcb.201112145</pub-id></citation></ref>
<ref id="ref36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Boer</surname> <given-names>E. M. J.</given-names></name> <name><surname>Orie</surname> <given-names>V. K.</given-names></name> <name><surname>Williams</surname> <given-names>T.</given-names></name> <name><surname>Baker</surname> <given-names>M. R.</given-names></name> <name><surname>De Oliveira</surname> <given-names>H. M.</given-names></name> <name><surname>Polvikoski</surname> <given-names>T.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>TDP-43 proteinopathies: a new wave of neurodegenerative diseases</article-title>. <source>J. Neurol. Neurosurg. Psychiatry</source> <volume>92</volume>, <fpage>86</fpage>&#x2013;<lpage>95</lpage>. doi: <pub-id pub-id-type="doi">10.1136/jnnp-2020-322983</pub-id></citation></ref>
<ref id="ref37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Devlin</surname> <given-names>A. C.</given-names></name> <name><surname>Burr</surname> <given-names>K.</given-names></name> <name><surname>Borooah</surname> <given-names>S.</given-names></name> <name><surname>Foster</surname> <given-names>J. D.</given-names></name> <name><surname>Cleary</surname> <given-names>E. M.</given-names></name> <name><surname>Geti</surname> <given-names>I.</given-names></name> <etal/></person-group>. (<year>2015</year>). <article-title>Human iPSC-derived motoneurons harbouring TARDBP or C9ORF72 ALS mutations are dysfunctional despite maintaining viability</article-title>. <source>Nat. Commun.</source> <volume>6</volume>:<fpage>5999</fpage>. doi: <pub-id pub-id-type="doi">10.1038/ncomms6999</pub-id></citation></ref>
<ref id="ref38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dewey</surname> <given-names>C. M.</given-names></name> <name><surname>Cenik</surname> <given-names>B.</given-names></name> <name><surname>Sephton</surname> <given-names>C. F.</given-names></name> <name><surname>Johnson</surname> <given-names>B. A.</given-names></name> <name><surname>Herz</surname> <given-names>J.</given-names></name> <name><surname>Yu</surname> <given-names>G.</given-names></name></person-group> (<year>2012</year>). <article-title>TDP-43 aggregation in neurodegeneration: are stress granules the key?</article-title> <source>Brain Res.</source> <volume>1462</volume>, <fpage>16</fpage>&#x2013;<lpage>25</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.brainres.2012.02.032</pub-id></citation></ref>
<ref id="ref39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Diaz-Garcia</surname> <given-names>S.</given-names></name> <name><surname>Ko</surname> <given-names>V. I.</given-names></name> <name><surname>Vazquez-Sanchez</surname> <given-names>S.</given-names></name> <name><surname>Chia</surname> <given-names>R.</given-names></name> <name><surname>Arogundade</surname> <given-names>O. A.</given-names></name> <name><surname>Rodriguez</surname> <given-names>M. J.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Nuclear depletion of RNA-binding protein ELAVL3 (HuC) in sporadic and familial amyotrophic lateral sclerosis</article-title>. <source>Acta Neuropathol.</source> <volume>142</volume>, <fpage>985</fpage>&#x2013;<lpage>1001</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00401-021-02374-4</pub-id></citation></ref>
<ref id="ref40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ederle</surname> <given-names>H.</given-names></name> <name><surname>Funk</surname> <given-names>C.</given-names></name> <name><surname>Abou-Ajram</surname> <given-names>C.</given-names></name> <name><surname>Hutten</surname> <given-names>S.</given-names></name> <name><surname>Funk</surname> <given-names>E. B. E.</given-names></name> <name><surname>Kehlenbach</surname> <given-names>R. H.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Nuclear egress of TDP-43 and FUS occurs independently of Exportin-1/CRM1</article-title>. <source>Sci. Rep.</source> <volume>8</volume>:<fpage>7084</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-018-25007-5</pub-id></citation></ref>
<ref id="ref41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Einhauer</surname> <given-names>A.</given-names></name> <name><surname>Jungbauer</surname> <given-names>A.</given-names></name></person-group> (<year>2001</year>). <article-title>The FLAG peptide, a versatile fusion tag for the purification of recombinant proteins</article-title>. <source>J. Biochem. Biophys. Methods</source> <volume>49</volume>, <fpage>455</fpage>&#x2013;<lpage>465</lpage>. doi: <pub-id pub-id-type="doi">10.1016/s0165-022x(01)00213-5</pub-id></citation></ref>
<ref id="ref42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fallini</surname> <given-names>C.</given-names></name> <name><surname>Bassell</surname> <given-names>G. J.</given-names></name> <name><surname>Rossoll</surname> <given-names>W.</given-names></name></person-group> (<year>2012</year>). <article-title>The ALS disease protein TDP-43 is actively transported in motor neuron axons and regulates axon outgrowth</article-title>. <source>Hum. Mol. Genet.</source> <volume>21</volume>, <fpage>3703</fpage>&#x2013;<lpage>3718</lpage>. doi: <pub-id pub-id-type="doi">10.1093/hmg/dds205</pub-id></citation></ref>
<ref id="ref43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname> <given-names>L. R.</given-names></name> <name><surname>Culver</surname> <given-names>D. G.</given-names></name> <name><surname>Tennant</surname> <given-names>P.</given-names></name> <name><surname>Davis</surname> <given-names>A. A.</given-names></name> <name><surname>Wang</surname> <given-names>M.</given-names></name> <name><surname>Castellano-Sanchez</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2004</year>). <article-title>Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man</article-title>. <source>Exp. Neurol.</source> <volume>185</volume>, <fpage>232</fpage>&#x2013;<lpage>240</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.expneurol.2003.10.004</pub-id></citation></ref>
<ref id="ref44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fogarty</surname> <given-names>M. J.</given-names></name></person-group> (<year>2019</year>). <article-title>Amyotrophic lateral sclerosis as a synaptopathy</article-title>. <source>Neural Regen. Res.</source> <volume>14</volume>, <fpage>189</fpage>&#x2013;<lpage>192</lpage>. doi: <pub-id pub-id-type="doi">10.4103/1673-5374.244782</pub-id></citation></ref>
<ref id="ref45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fogarty</surname> <given-names>M. J.</given-names></name> <name><surname>Kanjhan</surname> <given-names>R.</given-names></name> <name><surname>Bellingham</surname> <given-names>M. C.</given-names></name> <name><surname>Noakes</surname> <given-names>P. G.</given-names></name></person-group> (<year>2016a</year>). <article-title>Glycinergic neurotransmission: a potent regulator of embryonic motor neuron dendritic morphology and synaptic plasticity</article-title>. <source>J. Neurosci.</source> <volume>36</volume>, <fpage>80</fpage>&#x2013;<lpage>87</lpage>. doi: <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1576-15.2016</pub-id></citation></ref>
<ref id="ref46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fogarty</surname> <given-names>M. J.</given-names></name> <name><surname>Mu</surname> <given-names>E. W. H.</given-names></name> <name><surname>Lavidis</surname> <given-names>N. A.</given-names></name> <name><surname>Noakes</surname> <given-names>P. G.</given-names></name> <name><surname>Bellingham</surname> <given-names>M. C.</given-names></name></person-group> (<year>2017</year>). <article-title>Motor areas show altered dendritic structure in an amyotrophic lateral sclerosis mouse model</article-title>. <source>Front. Neurosci.</source> <volume>11</volume>:<fpage>609</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnins.2017.00609</pub-id></citation></ref>
<ref id="ref47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fogarty</surname> <given-names>M. J.</given-names></name> <name><surname>Mu</surname> <given-names>E. W.</given-names></name> <name><surname>Noakes</surname> <given-names>P. G.</given-names></name> <name><surname>Lavidis</surname> <given-names>N. A.</given-names></name> <name><surname>Bellingham</surname> <given-names>M. C.</given-names></name></person-group> (<year>2016b</year>). <article-title>Marked changes in dendritic structure and spine density precede significant neuronal death in vulnerable cortical pyramidal neuron populations in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis</article-title>. <source>Acta Neuropathol. Commun.</source> <volume>4</volume>:<fpage>77</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s40478-016-0347-y</pub-id></citation></ref>
<ref id="ref48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fratta</surname> <given-names>P.</given-names></name> <name><surname>Sivakumar</surname> <given-names>P.</given-names></name> <name><surname>Humphrey</surname> <given-names>J.</given-names></name> <name><surname>Lo</surname> <given-names>K.</given-names></name> <name><surname>Ricketts</surname> <given-names>T.</given-names></name> <name><surname>Oliveira</surname> <given-names>H.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Mice with endogenous TDP-43 mutations exhibit gain of splicing function and characteristics of amyotrophic lateral sclerosis</article-title>. <source>EMBO J.</source> <volume>37</volume>:<fpage>e98684</fpage>. doi: <pub-id pub-id-type="doi">10.15252/embj.201798684</pub-id></citation></ref>
<ref id="ref49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fusco</surname> <given-names>C. M.</given-names></name> <name><surname>Desch</surname> <given-names>K.</given-names></name> <name><surname>Dorrbaum</surname> <given-names>A. R.</given-names></name> <name><surname>Wang</surname> <given-names>M.</given-names></name> <name><surname>Staab</surname> <given-names>A.</given-names></name> <name><surname>Chan</surname> <given-names>I. C. W.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Neuronal ribosomes exhibit dynamic and context-dependent exchange of ribosomal proteins</article-title>. <source>Nat. Commun.</source> <volume>12</volume>:<fpage>6127</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-021-26365-x</pub-id></citation></ref>
<ref id="ref50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Genc</surname> <given-names>B.</given-names></name> <name><surname>Jara</surname> <given-names>J. H.</given-names></name> <name><surname>Schultz</surname> <given-names>M. C.</given-names></name> <name><surname>Manuel</surname> <given-names>M.</given-names></name> <name><surname>Stanford</surname> <given-names>M. J.</given-names></name> <name><surname>Gautam</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Absence of UCHL 1 function leads to selective motor neuropathy</article-title>. <source>Ann. Clin. Transl. Neurol.</source> <volume>3</volume>, <fpage>331</fpage>&#x2013;<lpage>345</lpage>. doi: <pub-id pub-id-type="doi">10.1002/acn3.298</pub-id></citation></ref>
<ref id="ref51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gil</surname> <given-names>J.</given-names></name> <name><surname>Funalot</surname> <given-names>B.</given-names></name> <name><surname>Verschueren</surname> <given-names>A.</given-names></name> <name><surname>Danel-Brunaud</surname> <given-names>V.</given-names></name> <name><surname>Camu</surname> <given-names>W.</given-names></name> <name><surname>Vandenberghe</surname> <given-names>N.</given-names></name> <etal/></person-group>. (<year>2008</year>). <article-title>Causes of death amongst French patients with amyotrophic lateral sclerosis: a prospective study</article-title>. <source>Eur. J. Neurol.</source> <volume>15</volume>, <fpage>1245</fpage>&#x2013;<lpage>1251</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1468-1331.2008.02307.x</pub-id></citation></ref>
<ref id="ref52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gitcho</surname> <given-names>M. A.</given-names></name> <name><surname>Baloh</surname> <given-names>R. H.</given-names></name> <name><surname>Chakraverty</surname> <given-names>S.</given-names></name> <name><surname>Mayo</surname> <given-names>K.</given-names></name> <name><surname>Norton</surname> <given-names>J. B.</given-names></name> <name><surname>Levitch</surname> <given-names>D.</given-names></name> <etal/></person-group>. (<year>2008</year>). <article-title>TDP-43 A315T mutation in familial motor neuron disease</article-title>. <source>Ann. Neurol.</source> <volume>63</volume>, <fpage>535</fpage>&#x2013;<lpage>538</lpage>. doi: <pub-id pub-id-type="doi">10.1002/ana.21344</pub-id></citation></ref>
<ref id="ref53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guatteo</surname> <given-names>E.</given-names></name> <name><surname>Carunchio</surname> <given-names>I.</given-names></name> <name><surname>Pieri</surname> <given-names>M.</given-names></name> <name><surname>Albo</surname> <given-names>F.</given-names></name> <name><surname>Canu</surname> <given-names>N.</given-names></name> <name><surname>Mercuri</surname> <given-names>N. B.</given-names></name> <etal/></person-group>. (<year>2007</year>). <article-title>Altered calcium homeostasis in motor neurons following AMPA receptor but not voltage-dependent calcium channels' activation in a genetic model of amyotrophic lateral sclerosis</article-title>. <source>Neurobiol. Dis.</source> <volume>28</volume>, <fpage>90</fpage>&#x2013;<lpage>100</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.nbd.2007.07.002</pub-id></citation></ref>
<ref id="ref54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname> <given-names>W.</given-names></name> <name><surname>Naujock</surname> <given-names>M.</given-names></name> <name><surname>Fumagalli</surname> <given-names>L.</given-names></name> <name><surname>Vandoorne</surname> <given-names>T.</given-names></name> <name><surname>Baatsen</surname> <given-names>P.</given-names></name> <name><surname>Boon</surname> <given-names>R.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients</article-title>. <source>Nat. Commun.</source> <volume>8</volume>:<fpage>861</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-017-00911-y</pub-id></citation></ref>
<ref id="ref55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname> <given-names>W.</given-names></name> <name><surname>Stoklund Dittlau</surname> <given-names>K.</given-names></name> <name><surname>Van Den Bosch</surname> <given-names>L.</given-names></name></person-group> (<year>2020</year>). <article-title>Axonal transport defects and neurodegeneration: molecular mechanisms and therapeutic implications</article-title>. <source>Semin. Cell Dev. Biol.</source> <volume>99</volume>, <fpage>133</fpage>&#x2013;<lpage>150</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.semcdb.2019.07.010</pub-id></citation></ref>
<ref id="ref56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Handley</surname> <given-names>E. E.</given-names></name> <name><surname>Pitman</surname> <given-names>K. A.</given-names></name> <name><surname>Dawkins</surname> <given-names>E.</given-names></name> <name><surname>Young</surname> <given-names>K. M.</given-names></name> <name><surname>Clark</surname> <given-names>R. M.</given-names></name> <name><surname>Jiang</surname> <given-names>T. C.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>Synapse dysfunction of layer V pyramidal neurons precedes neurodegeneration in a mouse model of TDP-43 Proteinopathies</article-title>. <source>Cereb. Cortex</source> <volume>27</volume>, <fpage>3630</fpage>&#x2013;<lpage>3647</lpage>. doi: <pub-id pub-id-type="doi">10.1093/cercor/bhw185</pub-id></citation></ref>
<ref id="ref57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hardiman</surname> <given-names>O.</given-names></name> <name><surname>Al-Chalabi</surname> <given-names>A.</given-names></name> <name><surname>Chio</surname> <given-names>A.</given-names></name> <name><surname>Corr</surname> <given-names>E. M.</given-names></name> <name><surname>Logroscino</surname> <given-names>G.</given-names></name> <name><surname>Robberecht</surname> <given-names>W.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>Amyotrophic lateral sclerosis</article-title>. <source>Nat. Rev. Dis. Primers.</source> <volume>3</volume>:<fpage>17085</fpage>. doi: <pub-id pub-id-type="doi">10.1038/nrdp.2017.85</pub-id></citation></ref>
<ref id="ref58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harrison</surname> <given-names>A. F.</given-names></name> <name><surname>Shorter</surname> <given-names>J.</given-names></name></person-group> (<year>2017</year>). <article-title>RNA-binding proteins with prion-like domains in health and disease</article-title>. <source>Biochem. J.</source> <volume>474</volume>, <fpage>1417</fpage>&#x2013;<lpage>1438</lpage>. doi: <pub-id pub-id-type="doi">10.1042/BCJ20160499</pub-id></citation></ref>
<ref id="ref59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Helmchen</surname> <given-names>F.</given-names></name> <name><surname>Svoboda</surname> <given-names>K.</given-names></name> <name><surname>Denk</surname> <given-names>W.</given-names></name> <name><surname>Tank</surname> <given-names>D. W.</given-names></name></person-group> (<year>1999</year>). <article-title>In vivo dendritic calcium dynamics in deep-layer cortical pyramidal neurons</article-title>. <source>Nat. Neurosci.</source> <volume>2</volume>, <fpage>989</fpage>&#x2013;<lpage>996</lpage>. doi: <pub-id pub-id-type="doi">10.1038/14788</pub-id></citation></ref>
<ref id="ref60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Higashi</surname> <given-names>S.</given-names></name> <name><surname>Kabuta</surname> <given-names>T.</given-names></name> <name><surname>Nagai</surname> <given-names>Y.</given-names></name> <name><surname>Tsuchiya</surname> <given-names>Y.</given-names></name> <name><surname>Akiyama</surname> <given-names>H.</given-names></name> <name><surname>Wada</surname> <given-names>K.</given-names></name></person-group> (<year>2013</year>). <article-title>TDP-43 associates with stalled ribosomes and contributes to cell survival during cellular stress</article-title>. <source>J. Neurochem.</source> <volume>126</volume>, <fpage>288</fpage>&#x2013;<lpage>300</lpage>. doi: <pub-id pub-id-type="doi">10.1111/jnc.12194</pub-id></citation></ref>
<ref id="ref61"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Igaz</surname> <given-names>L. M.</given-names></name> <name><surname>Kwong</surname> <given-names>L. K.</given-names></name> <name><surname>Lee</surname> <given-names>E. B.</given-names></name> <name><surname>Chen-Plotkin</surname> <given-names>A.</given-names></name> <name><surname>Swanson</surname> <given-names>E.</given-names></name> <name><surname>Unger</surname> <given-names>T.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title>Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice</article-title>. <source>J. Clin. Invest.</source> <volume>121</volume>, <fpage>726</fpage>&#x2013;<lpage>738</lpage>. doi: <pub-id pub-id-type="doi">10.1172/JCI44867</pub-id></citation></ref>
<ref id="ref62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname> <given-names>B. K.</given-names></name> <name><surname>Schuldi</surname> <given-names>M. H.</given-names></name> <name><surname>McAvoy</surname> <given-names>K.</given-names></name> <name><surname>Russell</surname> <given-names>K. A.</given-names></name> <name><surname>Boehringer</surname> <given-names>A.</given-names></name> <name><surname>Curran</surname> <given-names>B. M.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Synaptic dysfunction induced by glycine-alanine dipeptides in C9orf72-ALS/FTD is rescued by SV2 replenishment</article-title>. <source>EMBO Mol. Med.</source> <volume>12</volume>:<fpage>e10722</fpage>. doi: <pub-id pub-id-type="doi">10.15252/emmm.201910722</pub-id></citation></ref>
<ref id="ref63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname> <given-names>M. C.</given-names></name> <name><surname>Adimula</surname> <given-names>A.</given-names></name> <name><surname>Birch</surname> <given-names>D.</given-names></name> <name><surname>Heckman</surname> <given-names>C. J.</given-names></name></person-group> (<year>2017</year>). <article-title>Hyperexcitability in synaptic and firing activities of spinal motoneurons in an adult mouse model of amyotrophic lateral sclerosis</article-title>. <source>Neuroscience</source> <volume>362</volume>, <fpage>33</fpage>&#x2013;<lpage>46</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neuroscience.2017.08.041</pub-id></citation></ref>
<ref id="ref64"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname> <given-names>H.</given-names></name> <name><surname>Yoon</surname> <given-names>B. C.</given-names></name> <name><surname>Holt</surname> <given-names>C. E.</given-names></name></person-group> (<year>2012</year>). <article-title>Axonal mRNA localization and local protein synthesis in nervous system assembly, maintenance and repair</article-title>. <source>Nat. Rev. Neurosci.</source> <volume>13</volume>, <fpage>308</fpage>&#x2013;<lpage>324</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nrn3210</pub-id></citation></ref>
<ref id="ref65"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kato</surname> <given-names>S.</given-names></name> <name><surname>Kato</surname> <given-names>M.</given-names></name> <name><surname>Abe</surname> <given-names>Y.</given-names></name> <name><surname>Matsumura</surname> <given-names>T.</given-names></name> <name><surname>Nishino</surname> <given-names>T.</given-names></name> <name><surname>Aoki</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2005</year>). <article-title>Redox system expression in the motor neurons in amyotrophic lateral sclerosis (ALS): immunohistochemical studies on sporadic ALS, superoxide dismutase 1 (SOD1)-mutated familial ALS, and SOD1-mutated ALS animal models</article-title>. <source>Acta Neuropathol.</source> <volume>110</volume>, <fpage>101</fpage>&#x2013;<lpage>112</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00401-005-1019-3</pub-id></citation></ref>
<ref id="ref66"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kato</surname> <given-names>S.</given-names></name> <name><surname>Saeki</surname> <given-names>Y.</given-names></name> <name><surname>Aoki</surname> <given-names>M.</given-names></name> <name><surname>Nagai</surname> <given-names>M.</given-names></name> <name><surname>Ishigaki</surname> <given-names>A.</given-names></name> <name><surname>Itoyama</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2004</year>). <article-title>Histological evidence of redox system breakdown caused by superoxide dismutase 1 (SOD1) aggregation is common to SOD1-mutated motor neurons in humans and animal models</article-title>. <source>Acta Neuropathol.</source> <volume>107</volume>, <fpage>149</fpage>&#x2013;<lpage>158</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00401-003-0791-1</pub-id></citation></ref>
<ref id="ref67"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>E.</given-names></name> <name><surname>Jung</surname> <given-names>H.</given-names></name></person-group> (<year>2020</year>). <article-title>Local mRNA translation in long-term maintenance of axon health and function</article-title>. <source>Curr. Opin. Neurobiol.</source> <volume>63</volume>, <fpage>15</fpage>&#x2013;<lpage>22</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.conb.2020.01.006</pub-id></citation></ref>
<ref id="ref68"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kraemer</surname> <given-names>B. C.</given-names></name> <name><surname>Schuck</surname> <given-names>T.</given-names></name> <name><surname>Wheeler</surname> <given-names>J. M.</given-names></name> <name><surname>Robinson</surname> <given-names>L. C.</given-names></name> <name><surname>Trojanowski</surname> <given-names>J. Q.</given-names></name> <name><surname>Lee</surname> <given-names>V. M.</given-names></name> <etal/></person-group>. (<year>2010</year>). <article-title>Loss of murine TDP-43 disrupts motor function and plays an essential role in embryogenesis</article-title>. <source>Acta Neuropathol.</source> <volume>119</volume>, <fpage>409</fpage>&#x2013;<lpage>419</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00401-010-0659-0</pub-id></citation></ref>
<ref id="ref69"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krishnamurthy</surname> <given-names>K.</given-names></name> <name><surname>Pasinelli</surname> <given-names>P.</given-names></name></person-group> (<year>2021</year>). <article-title>Synaptic dysfunction in amyotrophic lateral sclerosis/frontotemporal dementia: therapeutic strategies and novel biomarkers</article-title>. <source>J. Neurosci. Res.</source> <volume>99</volume>, <fpage>1499</fpage>&#x2013;<lpage>1503</lpage>. doi: <pub-id pub-id-type="doi">10.1002/jnr.24824</pub-id></citation></ref>
<ref id="ref70"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Larkum</surname> <given-names>M. E.</given-names></name> <name><surname>Zhu</surname> <given-names>J. J.</given-names></name> <name><surname>Sakmann</surname> <given-names>B.</given-names></name></person-group> (<year>1999</year>). <article-title>A new cellular mechanism for coupling inputs arriving at different cortical layers</article-title>. <source>Nature</source> <volume>398</volume>, <fpage>338</fpage>&#x2013;<lpage>341</lpage>. doi: <pub-id pub-id-type="doi">10.1038/18686</pub-id></citation></ref>
<ref id="ref71"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lazarenko</surname> <given-names>R. M.</given-names></name> <name><surname>DelBove</surname> <given-names>C. E.</given-names></name> <name><surname>Zhang</surname> <given-names>Q.</given-names></name></person-group> (<year>2018</year>). <article-title>Fluorescent measurement of synaptic activity using FM dyes in dissociated hippocampal cultured neurons</article-title>. <source>Bio Protoc</source> <volume>8</volume>:<fpage>e2690</fpage>. doi: <pub-id pub-id-type="doi">10.21769/BioProtoc.2690</pub-id></citation></ref>
<ref id="ref72"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>S. J.</given-names></name> <name><surname>Oses-Prieto</surname> <given-names>J. A.</given-names></name> <name><surname>Kawaguchi</surname> <given-names>R.</given-names></name> <name><surname>Sahoo</surname> <given-names>P. K.</given-names></name> <name><surname>Kar</surname> <given-names>A. N.</given-names></name> <name><surname>Rozenbaum</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>hnRNPs interacting with mRNA localization motifs define axonal RNA regulons</article-title>. <source>Mol. Cell. Proteomics</source> <volume>17</volume>, <fpage>2091</fpage>&#x2013;<lpage>2106</lpage>. doi: <pub-id pub-id-type="doi">10.1074/mcp.RA118.000603</pub-id></citation></ref>
<ref id="ref73"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lehmkuhl</surname> <given-names>E. M.</given-names></name> <name><surname>Loganathan</surname> <given-names>S.</given-names></name> <name><surname>Alsop</surname> <given-names>E.</given-names></name> <name><surname>Blythe</surname> <given-names>A. D.</given-names></name> <name><surname>Kovalik</surname> <given-names>T.</given-names></name> <name><surname>Mortimore</surname> <given-names>N. P.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>TDP-43 proteinopathy alters the ribosome association of multiple mRNAs including the glypican dally-like protein (Dlp)/GPC6</article-title>. <source>Acta Neuropathol. Commun.</source> <volume>9</volume>:<fpage>52</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s40478-021-01148-z</pub-id></citation></ref>
<ref id="ref74"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname> <given-names>B.</given-names></name> <name><surname>Zhao</surname> <given-names>W.</given-names></name> <name><surname>Beers</surname> <given-names>D. R.</given-names></name> <name><surname>Henkel</surname> <given-names>J. S.</given-names></name> <name><surname>Appel</surname> <given-names>S. H.</given-names></name></person-group> (<year>2012</year>). <article-title>Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS</article-title>. <source>Exp. Neurol.</source> <volume>237</volume>, <fpage>147</fpage>&#x2013;<lpage>152</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.expneurol.2012.06.011</pub-id></citation></ref>
<ref id="ref75"><citation citation-type="other"><person-group person-group-type="author"><name><surname>Limone</surname> <given-names>F.</given-names></name> <name><surname>Mordes</surname> <given-names>D.</given-names></name> <name><surname>Couto</surname> <given-names>A.</given-names></name> <name><surname>Pietil&#x00E4;inen</surname> <given-names>O.</given-names></name> <name><surname>Joseph</surname> <given-names>B. J.</given-names></name> <name><surname>Burberry</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2021</year>). Single-nucleus sequencing reveals enriched expression of genetic risk factors sensitises motor neurons to degeneration in ALS. bioRxiv [Preprint], 1&#x2013;9.</citation></ref>
<ref id="ref76"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ling</surname> <given-names>S. C.</given-names></name> <name><surname>Polymenidou</surname> <given-names>M.</given-names></name> <name><surname>Cleveland</surname> <given-names>D. W.</given-names></name></person-group> (<year>2013</year>). <article-title>Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis</article-title>. <source>Neuron</source> <volume>79</volume>, <fpage>416</fpage>&#x2013;<lpage>438</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neuron.2013.07.033</pub-id></citation></ref>
<ref id="ref77"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>J.</given-names></name> <name><surname>Su</surname> <given-names>G.</given-names></name> <name><surname>Gao</surname> <given-names>J.</given-names></name> <name><surname>Tian</surname> <given-names>Y.</given-names></name> <name><surname>Liu</surname> <given-names>X.</given-names></name> <name><surname>Zhang</surname> <given-names>Z.</given-names></name></person-group> (<year>2020</year>). <article-title>Effects of Peroxiredoxin 2 in neurological disorders: a review of its molecular mechanisms</article-title>. <source>Neurochem. Res.</source> <volume>45</volume>, <fpage>720</fpage>&#x2013;<lpage>730</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11064-020-02971-x</pub-id></citation></ref>
<ref id="ref78"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>J.</given-names></name> <name><surname>Wang</surname> <given-names>F.</given-names></name></person-group> (<year>2017</year>). <article-title>Role of Neuroinflammation in amyotrophic lateral sclerosis: cellular mechanisms and therapeutic implications</article-title>. <source>Front. Immunol.</source> <volume>8</volume>:<fpage>1005</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2017.01005</pub-id></citation></ref>
<ref id="ref79"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mackenzie</surname> <given-names>I. R.</given-names></name> <name><surname>Neumann</surname> <given-names>M.</given-names></name> <name><surname>Baborie</surname> <given-names>A.</given-names></name> <name><surname>Sampathu</surname> <given-names>D. M.</given-names></name> <name><surname>Du Plessis</surname> <given-names>D.</given-names></name> <name><surname>Jaros</surname> <given-names>E.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title>A harmonized classification system for FTLD-TDP pathology</article-title>. <source>Acta Neuropathol.</source> <volume>122</volume>, <fpage>111</fpage>&#x2013;<lpage>113</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00401-011-0845-8</pub-id></citation></ref>
<ref id="ref80"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mani</surname> <given-names>M.</given-names></name> <name><surname>Lee</surname> <given-names>S. Y.</given-names></name> <name><surname>Lucast</surname> <given-names>L.</given-names></name> <name><surname>Cremona</surname> <given-names>O.</given-names></name> <name><surname>Di Paolo</surname> <given-names>G.</given-names></name> <name><surname>De Camilli</surname> <given-names>P.</given-names></name> <etal/></person-group>. (<year>2007</year>). <article-title>The dual phosphatase activity of synaptojanin1 is required for both efficient synaptic vesicle endocytosis and reavailability at nerve terminals</article-title>. <source>Neuron</source> <volume>56</volume>, <fpage>1004</fpage>&#x2013;<lpage>1018</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neuron.2007.10.032</pub-id></citation></ref>
<ref id="ref81"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marchetto</surname> <given-names>M. C.</given-names></name> <name><surname>Muotri</surname> <given-names>A. R.</given-names></name> <name><surname>Mu</surname> <given-names>Y.</given-names></name> <name><surname>Smith</surname> <given-names>A. M.</given-names></name> <name><surname>Cezar</surname> <given-names>G. G.</given-names></name> <name><surname>Gage</surname> <given-names>F. H.</given-names></name></person-group> (<year>2008</year>). <article-title>Non-cell-autonomous effect of human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cells</article-title>. <source>Cell Stem Cell</source> <volume>3</volume>, <fpage>649</fpage>&#x2013;<lpage>657</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.stem.2008.10.001</pub-id></citation></ref>
<ref id="ref82"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martinez</surname> <given-names>J. C.</given-names></name> <name><surname>Randolph</surname> <given-names>L. K.</given-names></name> <name><surname>Iascone</surname> <given-names>D. M.</given-names></name> <name><surname>Pernice</surname> <given-names>H. F.</given-names></name> <name><surname>Polleux</surname> <given-names>F.</given-names></name> <name><surname>Hengst</surname> <given-names>U.</given-names></name></person-group> (<year>2019</year>). <article-title>Pum2 shapes the transcriptome in developing axons through retention of target mRNAs in the cell body</article-title>. <source>Neuron</source> <volume>104</volume>, <fpage>931</fpage>&#x2013;<lpage>946 e935</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neuron.2019.08.035</pub-id></citation></ref>
<ref id="ref83"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matsuki</surname> <given-names>H.</given-names></name> <name><surname>Takahashi</surname> <given-names>M.</given-names></name> <name><surname>Higuchi</surname> <given-names>M.</given-names></name> <name><surname>Makokha</surname> <given-names>G. N.</given-names></name> <name><surname>Oie</surname> <given-names>M.</given-names></name> <name><surname>Fujii</surname> <given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>Both G3BP1 and G3BP2 contribute to stress granule formation</article-title>. <source>Genes Cells</source> <volume>18</volume>, <fpage>135</fpage>&#x2013;<lpage>146</lpage>. doi: <pub-id pub-id-type="doi">10.1111/gtc.12023</pub-id></citation></ref>
<ref id="ref84"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname> <given-names>S. E.</given-names></name> <name><surname>Mathiasen</surname> <given-names>S.</given-names></name> <name><surname>Bright</surname> <given-names>N. A.</given-names></name> <name><surname>Pierre</surname> <given-names>F.</given-names></name> <name><surname>Kelly</surname> <given-names>B. T.</given-names></name> <name><surname>Kladt</surname> <given-names>N.</given-names></name> <etal/></person-group>. (<year>2015</year>). <article-title>CALM regulates clathrin-coated vesicle size and maturation by directly sensing and driving membrane curvature</article-title>. <source>Dev. Cell</source> <volume>33</volume>, <fpage>163</fpage>&#x2013;<lpage>175</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.devcel.2015.03.002</pub-id></citation></ref>
<ref id="ref85"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mitani</surname> <given-names>T. T.</given-names></name> <name><surname>Beck</surname> <given-names>G.</given-names></name> <name><surname>Kido</surname> <given-names>K.</given-names></name> <name><surname>Yamashita</surname> <given-names>R.</given-names></name> <name><surname>Yonenobu</surname> <given-names>Y.</given-names></name> <name><surname>Ogawa</surname> <given-names>T.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Amyotrophic lateral sclerosis with speech apraxia, predominant upper motor neuron signs, and prominent iron accumulation in the frontal operculum and precentral gyrus</article-title>. <source>Neuropathology</source> <volume>41</volume>, <fpage>324</fpage>&#x2013;<lpage>331</lpage>. doi: <pub-id pub-id-type="doi">10.1111/neup.12763</pub-id></citation></ref>
<ref id="ref86"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moloney</surname> <given-names>E. B.</given-names></name> <name><surname>de Winter</surname> <given-names>F.</given-names></name> <name><surname>Verhaagen</surname> <given-names>J.</given-names></name></person-group> (<year>2014</year>). <article-title>ALS as a distal axonopathy: molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease</article-title>. <source>Front. Neurosci.</source> <volume>8</volume>:<fpage>252</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnins.2014.00252</pub-id></citation></ref>
<ref id="ref87"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Molyneaux</surname> <given-names>B. J.</given-names></name> <name><surname>Arlotta</surname> <given-names>P.</given-names></name> <name><surname>Menezes</surname> <given-names>J. R.</given-names></name> <name><surname>Macklis</surname> <given-names>J. D.</given-names></name></person-group> (<year>2007</year>). <article-title>Neuronal subtype specification in the cerebral cortex</article-title>. <source>Nat. Rev. Neurosci.</source> <volume>8</volume>, <fpage>427</fpage>&#x2013;<lpage>437</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nrn2151</pub-id></citation></ref>
<ref id="ref88"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nagano</surname> <given-names>S.</given-names></name> <name><surname>Jinno</surname> <given-names>J.</given-names></name> <name><surname>Abdelhamid</surname> <given-names>R. F.</given-names></name> <name><surname>Jin</surname> <given-names>Y.</given-names></name> <name><surname>Shibata</surname> <given-names>M.</given-names></name> <name><surname>Watanabe</surname> <given-names>S.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>TDP-43 transports ribosomal protein mRNA to regulate axonal local translation in neuronal axons</article-title>. <source>Acta Neuropathol.</source> <volume>140</volume>, <fpage>695</fpage>&#x2013;<lpage>713</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00401-020-02205-y</pub-id></citation></ref>
<ref id="ref89"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Naujock</surname> <given-names>M.</given-names></name> <name><surname>Stanslowsky</surname> <given-names>N.</given-names></name> <name><surname>Bufler</surname> <given-names>S.</given-names></name> <name><surname>Naumann</surname> <given-names>M.</given-names></name> <name><surname>Reinhardt</surname> <given-names>P.</given-names></name> <name><surname>Sterneckert</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>4-Aminopyridine induced activity rescues Hypoexcitable motor neurons from amyotrophic lateral sclerosis patient-derived induced pluripotent stem cells</article-title>. <source>Stem Cells</source> <volume>34</volume>, <fpage>1563</fpage>&#x2013;<lpage>1575</lpage>. doi: <pub-id pub-id-type="doi">10.1002/stem.2354</pub-id></citation></ref>
<ref id="ref90"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Naumann</surname> <given-names>M.</given-names></name> <name><surname>Pal</surname> <given-names>A.</given-names></name> <name><surname>Goswami</surname> <given-names>A.</given-names></name> <name><surname>Lojewski</surname> <given-names>X.</given-names></name> <name><surname>Japtok</surname> <given-names>J.</given-names></name> <name><surname>Vehlow</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation</article-title>. <source>Nat. Commun.</source> <volume>9</volume>:<fpage>335</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-017-02299-1</pub-id></citation></ref>
<ref id="ref91"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Negro</surname> <given-names>S.</given-names></name> <name><surname>Stazi</surname> <given-names>M.</given-names></name> <name><surname>Marchioretto</surname> <given-names>M.</given-names></name> <name><surname>Tebaldi</surname> <given-names>T.</given-names></name> <name><surname>Rodella</surname> <given-names>U.</given-names></name> <name><surname>Duregotti</surname> <given-names>E.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Hydrogen peroxide is a neuronal alarmin that triggers specific RNAs, local translation of Annexin A2, and cytoskeletal remodeling in Schwann cells</article-title>. <source>RNA</source> <volume>24</volume>, <fpage>915</fpage>&#x2013;<lpage>925</lpage>. doi: <pub-id pub-id-type="doi">10.1261/rna.064816.117</pub-id></citation></ref>
<ref id="ref92"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Neumann</surname> <given-names>M.</given-names></name></person-group> (<year>2009</year>). <article-title>Molecular neuropathology of TDP-43 proteinopathies</article-title>. <source>Int. J. Mol. Sci.</source> <volume>10</volume>, <fpage>232</fpage>&#x2013;<lpage>246</lpage>. doi: <pub-id pub-id-type="doi">10.3390/ijms10010232</pub-id></citation></ref>
<ref id="ref93"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Neumann</surname> <given-names>M.</given-names></name> <name><surname>Sampathu</surname> <given-names>D. M.</given-names></name> <name><surname>Kwong</surname> <given-names>L. K.</given-names></name> <name><surname>Truax</surname> <given-names>A. C.</given-names></name> <name><surname>Micsenyi</surname> <given-names>M. C.</given-names></name> <name><surname>Chou</surname> <given-names>T. T.</given-names></name> <etal/></person-group>. (<year>2006</year>). <article-title>Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis</article-title>. <source>Science</source> <volume>314</volume>, <fpage>130</fpage>&#x2013;<lpage>133</lpage>. doi: <pub-id pub-id-type="doi">10.1126/science.1134108</pub-id></citation></ref>
<ref id="ref94"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Niedermeyer</surname> <given-names>S.</given-names></name> <name><surname>Murn</surname> <given-names>M.</given-names></name> <name><surname>Choi</surname> <given-names>P. J.</given-names></name></person-group> (<year>2019</year>). <article-title>Respiratory failure in amyotrophic lateral sclerosis</article-title>. <source>Chest</source> <volume>155</volume>, <fpage>401</fpage>&#x2013;<lpage>408</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.chest.2018.06.035</pub-id></citation></ref>
<ref id="ref95"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ostroff</surname> <given-names>L. E.</given-names></name> <name><surname>Santini</surname> <given-names>E.</given-names></name> <name><surname>Sears</surname> <given-names>R.</given-names></name> <name><surname>Deane</surname> <given-names>Z.</given-names></name> <name><surname>Kanadia</surname> <given-names>R. N.</given-names></name> <name><surname>LeDoux</surname> <given-names>J. E.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Axon TRAP reveals learning-associated alterations in cortical axonal mRNAs in the lateral amgydala</article-title>. <source>Elife</source> <volume>8</volume>:<fpage>e51607</fpage>. doi: <pub-id pub-id-type="doi">10.7554/eLife.51607</pub-id></citation></ref>
<ref id="ref96"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pelizzoni</surname> <given-names>I.</given-names></name> <name><surname>Macco</surname> <given-names>R.</given-names></name> <name><surname>Zacchetti</surname> <given-names>D.</given-names></name> <name><surname>Grohovaz</surname> <given-names>F.</given-names></name> <name><surname>Codazzi</surname> <given-names>F.</given-names></name></person-group> (<year>2008</year>). <article-title>Iron and calcium in the central nervous system: a close relationship in health and sickness</article-title>. <source>Biochem. Soc. Trans.</source> <volume>36</volume>, <fpage>1309</fpage>&#x2013;<lpage>1312</lpage>. doi: <pub-id pub-id-type="doi">10.1042/BST0361309</pub-id></citation></ref>
<ref id="ref97"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Perkins</surname> <given-names>E. M.</given-names></name> <name><surname>Burr</surname> <given-names>K.</given-names></name> <name><surname>Banerjee</surname> <given-names>P.</given-names></name> <name><surname>Mehta</surname> <given-names>A. R.</given-names></name> <name><surname>Dando</surname> <given-names>O.</given-names></name> <name><surname>Selvaraj</surname> <given-names>B. T.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Altered network properties in C9ORF72 repeat expansion cortical neurons are due to synaptic dysfunction</article-title>. <source>Mol. Neurodegener.</source> <volume>16</volume>:<fpage>13</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13024-021-00433-8</pub-id></citation></ref>
<ref id="ref98"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pharaoh</surname> <given-names>G.</given-names></name> <name><surname>Sataranatarajan</surname> <given-names>K.</given-names></name> <name><surname>Street</surname> <given-names>K.</given-names></name> <name><surname>Hill</surname> <given-names>S.</given-names></name> <name><surname>Gregston</surname> <given-names>J.</given-names></name> <name><surname>Ahn</surname> <given-names>B.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Metabolic and stress response changes precede disease onset in the spinal cord of mutant SOD1 ALS mice</article-title>. <source>Front. Neurosci.</source> <volume>13</volume>:<fpage>487</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnins.2019.00487</pub-id></citation></ref>
<ref id="ref99"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Polymenidou</surname> <given-names>M.</given-names></name> <name><surname>Lagier-Tourenne</surname> <given-names>C.</given-names></name> <name><surname>Hutt</surname> <given-names>K. R.</given-names></name> <name><surname>Huelga</surname> <given-names>S. C.</given-names></name> <name><surname>Moran</surname> <given-names>J.</given-names></name> <name><surname>Liang</surname> <given-names>T. Y.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title>Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43</article-title>. <source>Nat. Neurosci.</source> <volume>14</volume>, <fpage>459</fpage>&#x2013;<lpage>468</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nn.2779</pub-id></citation></ref>
<ref id="ref100"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Prasad</surname> <given-names>A.</given-names></name> <name><surname>Bharathi</surname> <given-names>V.</given-names></name> <name><surname>Sivalingam</surname> <given-names>V.</given-names></name> <name><surname>Girdhar</surname> <given-names>A.</given-names></name> <name><surname>Patel</surname> <given-names>B. K.</given-names></name></person-group> (<year>2019</year>). <article-title>Molecular mechanisms of TDP-43 Misfolding and pathology in amyotrophic lateral sclerosis</article-title>. <source>Front. Mol. Neurosci.</source> <volume>12</volume>:<fpage>25</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnmol.2019.00025</pub-id></citation></ref>
<ref id="ref101"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ragagnin</surname> <given-names>A. M. G.</given-names></name> <name><surname>Shadfar</surname> <given-names>S.</given-names></name> <name><surname>Vidal</surname> <given-names>M.</given-names></name> <name><surname>Jamali</surname> <given-names>M. S.</given-names></name> <name><surname>Atkin</surname> <given-names>J. D.</given-names></name></person-group> (<year>2019</year>). <article-title>Motor neuron susceptibility in ALS/FTD</article-title>. <source>Front. Neurosci.</source> <volume>13</volume>:<fpage>532</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnins.2019.00532</pub-id></citation></ref>
<ref id="ref102"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rosato</surname> <given-names>C.</given-names></name> <name><surname>Bettegazzi</surname> <given-names>B.</given-names></name> <name><surname>Intagliata</surname> <given-names>P.</given-names></name> <name><surname>Balbontin Arenas</surname> <given-names>M.</given-names></name> <name><surname>Zacchetti</surname> <given-names>D.</given-names></name> <name><surname>Lanati</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2022</year>). <article-title>Redox and calcium alterations of a Muller cell line exposed to diabetic retinopathy-like environment</article-title>. <source>Front. Cell. Neurosci.</source> <volume>16</volume>:<fpage>862325</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fncel.2022.862325</pub-id></citation></ref>
<ref id="ref103"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roy</surname> <given-names>S.</given-names></name></person-group> (<year>2020</year>). <article-title>Finding order in slow axonal transport</article-title>. <source>Curr. Opin. Neurobiol.</source> <volume>63</volume>, <fpage>87</fpage>&#x2013;<lpage>94</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.conb.2020.03.015</pub-id></citation></ref>
<ref id="ref104"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sambri</surname> <given-names>I.</given-names></name> <name><surname>Massa</surname> <given-names>F.</given-names></name> <name><surname>Gullo</surname> <given-names>F.</given-names></name> <name><surname>Meneghini</surname> <given-names>S.</given-names></name> <name><surname>Cassina</surname> <given-names>L.</given-names></name> <name><surname>Carraro</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Impaired flickering of the permeability transition pore causes SPG7 spastic paraplegia</article-title>. <source>EBioMedicine</source> <volume>61</volume>:<fpage>103050</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ebiom.2020.103050</pub-id></citation></ref>
<ref id="ref105"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sareen</surname> <given-names>D.</given-names></name> <name><surname>O'Rourke</surname> <given-names>J. G.</given-names></name> <name><surname>Meera</surname> <given-names>P.</given-names></name> <name><surname>Muhammad</surname> <given-names>A. K.</given-names></name> <name><surname>Grant</surname> <given-names>S.</given-names></name> <name><surname>Simpkinson</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion</article-title>. <source>Sci. Transl. Med.</source> <volume>5</volume>:<fpage>208ra149</fpage>. doi: <pub-id pub-id-type="doi">10.1126/scitranslmed.3007529</pub-id></citation></ref>
<ref id="ref106"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shigeoka</surname> <given-names>T.</given-names></name> <name><surname>Jung</surname> <given-names>H.</given-names></name> <name><surname>Jung</surname> <given-names>J.</given-names></name> <name><surname>Turner-Bridger</surname> <given-names>B.</given-names></name> <name><surname>Ohk</surname> <given-names>J.</given-names></name> <name><surname>Lin</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Dynamic axonal translation in developing and mature visual circuits</article-title>. <source>Cells</source> <volume>166</volume>, <fpage>181</fpage>&#x2013;<lpage>192</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2016.05.029</pub-id></citation></ref>
<ref id="ref107"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shigeoka</surname> <given-names>T.</given-names></name> <name><surname>Koppers</surname> <given-names>M.</given-names></name> <name><surname>Wong</surname> <given-names>H. H.</given-names></name> <name><surname>Lin</surname> <given-names>J. Q.</given-names></name> <name><surname>Cagnetta</surname> <given-names>R.</given-names></name> <name><surname>Dwivedy</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>On-site ribosome Remodeling by locally synthesized ribosomal proteins in axons</article-title>. <source>Cell Rep.</source> <volume>29</volume>, <fpage>3605</fpage>&#x2013;<lpage>3619 e3610</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.celrep.2019.11.025</pub-id></citation></ref>
<ref id="ref108"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Sidib&#x00E9;</surname> <given-names>H.</given-names></name> <name><surname>Vande Velde</surname> <given-names>C.</given-names></name></person-group> (<year>2019</year>). &#x201C;<article-title>RNA granules and their role in neurodegenerative diseases</article-title>&#x201D; in <source>The biology of mRNA: Structure and function</source>. eds. <person-group person-group-type="editor"><name><surname>Oeffinger</surname> <given-names>M.</given-names></name> <name><surname>Zenklusen</surname> <given-names>D.</given-names></name></person-group> (<publisher-loc>Cham</publisher-loc>: <publisher-name>Springer International Publishing</publisher-name>), <fpage>195</fpage>&#x2013;<lpage>245</lpage>.</citation></ref>
<ref id="ref109"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sirabella</surname> <given-names>R.</given-names></name> <name><surname>Valsecchi</surname> <given-names>V.</given-names></name> <name><surname>Anzilotti</surname> <given-names>S.</given-names></name> <name><surname>Cuomo</surname> <given-names>O.</given-names></name> <name><surname>Vinciguerra</surname> <given-names>A.</given-names></name> <name><surname>Cepparulo</surname> <given-names>P.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Ionic homeostasis maintenance in ALS: focus on new therapeutic targets</article-title>. <source>Front. Neurosci.</source> <volume>12</volume>:<fpage>510</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnins.2018.00510</pub-id></citation></ref>
<ref id="ref110"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sommer</surname> <given-names>D.</given-names></name> <name><surname>Rajkumar</surname> <given-names>S.</given-names></name> <name><surname>Seidel</surname> <given-names>M.</given-names></name> <name><surname>Aly</surname> <given-names>A.</given-names></name> <name><surname>Ludolph</surname> <given-names>A.</given-names></name> <name><surname>Ho</surname> <given-names>R.</given-names></name> <etal/></person-group>. (<year>2022</year>). <article-title>Aging-dependent altered transcriptional programs underlie activity impairments in human C9orf72-mutant motor neurons</article-title>. <source>Front. Mol. Neurosci.</source> <volume>15</volume>:<fpage>894230</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnmol.2022.894230</pub-id></citation></ref>
<ref id="ref111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sreedharan</surname> <given-names>J.</given-names></name> <name><surname>Blair</surname> <given-names>I. P.</given-names></name> <name><surname>Tripathi</surname> <given-names>V. B.</given-names></name> <name><surname>Hu</surname> <given-names>X.</given-names></name> <name><surname>Vance</surname> <given-names>C.</given-names></name> <name><surname>Rogelj</surname> <given-names>B.</given-names></name> <etal/></person-group>. (<year>2008</year>). <article-title>TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis</article-title>. <source>Science</source> <volume>319</volume>, <fpage>1668</fpage>&#x2013;<lpage>1672</lpage>. doi: <pub-id pub-id-type="doi">10.1126/science.1154584</pub-id></citation></ref>
<ref id="ref112"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Streit</surname> <given-names>L.</given-names></name> <name><surname>Kuhn</surname> <given-names>T.</given-names></name> <name><surname>Vomhof</surname> <given-names>T.</given-names></name> <name><surname>Bopp</surname> <given-names>V.</given-names></name> <name><surname>Ludolph</surname> <given-names>A. C.</given-names></name> <name><surname>Weishaupt</surname> <given-names>J. H.</given-names></name> <etal/></person-group>. (<year>2022</year>). <article-title>Stress induced TDP-43 mobility loss independent of stress granules</article-title>. <source>Nat. Commun.</source> <volume>13</volume>:<fpage>5480</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-022-32939-0</pub-id></citation></ref>
<ref id="ref113"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Strong</surname> <given-names>M. J.</given-names></name> <name><surname>Volkening</surname> <given-names>K.</given-names></name> <name><surname>Hammond</surname> <given-names>R.</given-names></name> <name><surname>Yang</surname> <given-names>W.</given-names></name> <name><surname>Strong</surname> <given-names>W.</given-names></name> <name><surname>Leystra-Lantz</surname> <given-names>C.</given-names></name> <etal/></person-group>. (<year>2007</year>). <article-title>TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein</article-title>. <source>Mol. Cell. Neurosci.</source> <volume>35</volume>, <fpage>320</fpage>&#x2013;<lpage>327</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.mcn.2007.03.007</pub-id></citation></ref>
<ref id="ref114"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Suk</surname> <given-names>T. R.</given-names></name> <name><surname>Rousseaux</surname> <given-names>M. W. C.</given-names></name></person-group> (<year>2020</year>). <article-title>The role of TDP-43 mislocalization in amyotrophic lateral sclerosis</article-title>. <source>Mol. Neurodegener.</source> <volume>15</volume>:<fpage>45</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13024-020-00397-1</pub-id></citation></ref>
<ref id="ref115"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname> <given-names>A. M.</given-names></name> <name><surname>Blurton-Jones</surname> <given-names>M.</given-names></name> <name><surname>Rhee</surname> <given-names>S. W.</given-names></name> <name><surname>Cribbs</surname> <given-names>D. H.</given-names></name> <name><surname>Cotman</surname> <given-names>C. W.</given-names></name> <name><surname>Jeon</surname> <given-names>N. L.</given-names></name></person-group> (<year>2005</year>). <article-title>A microfluidic culture platform for CNS axonal injury, regeneration and transport</article-title>. <source>Nat. Methods</source> <volume>2</volume>, <fpage>599</fpage>&#x2013;<lpage>605</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nmeth777</pub-id></citation></ref>
<ref id="ref116"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tollervey</surname> <given-names>J. R.</given-names></name> <name><surname>Curk</surname> <given-names>T.</given-names></name> <name><surname>Rogelj</surname> <given-names>B.</given-names></name> <name><surname>Briese</surname> <given-names>M.</given-names></name> <name><surname>Cereda</surname> <given-names>M.</given-names></name> <name><surname>Kayikci</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title>Characterizing the RNA targets and position-dependent splicing regulation by TDP-43</article-title>. <source>Nat. Neurosci.</source> <volume>14</volume>, <fpage>452</fpage>&#x2013;<lpage>458</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nn.2778</pub-id></citation></ref>
<ref id="ref117"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>van Rheenen</surname> <given-names>W.</given-names></name> <name><surname>van der Spek</surname> <given-names>R. A. A.</given-names></name> <name><surname>Bakker</surname> <given-names>M. K.</given-names></name> <name><surname>van Vugt</surname> <given-names>J.</given-names></name> <name><surname>Hop</surname> <given-names>P. J.</given-names></name> <name><surname>Zwamborn</surname> <given-names>R. A. J.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology</article-title>. <source>Nat. Genet.</source> <volume>53</volume>, <fpage>1636</fpage>&#x2013;<lpage>1648</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41588-021-00973-1</pub-id></citation></ref>
<ref id="ref118"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vannocci</surname> <given-names>T.</given-names></name> <name><surname>Notario Manzano</surname> <given-names>R.</given-names></name> <name><surname>Beccalli</surname> <given-names>O.</given-names></name> <name><surname>Bettegazzi</surname> <given-names>B.</given-names></name> <name><surname>Grohovaz</surname> <given-names>F.</given-names></name> <name><surname>Cinque</surname> <given-names>G.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Adding a temporal dimension to the study of Friedreich's ataxia: the effect of frataxin overexpression in a human cell model</article-title>. <source>Dis. Model. Mech.</source> <volume>11</volume>:<fpage>dmm032706</fpage>. doi: <pub-id pub-id-type="doi">10.1242/dmm.032706</pub-id></citation></ref>
<ref id="ref119"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>L.</given-names></name> <name><surname>Gutmann</surname> <given-names>D. H.</given-names></name> <name><surname>Roos</surname> <given-names>R. P.</given-names></name></person-group> (<year>2011</year>). <article-title>Astrocyte loss of mutant SOD1 delays ALS disease onset and progression in G85R transgenic mice</article-title>. <source>Hum. Mol. Genet.</source> <volume>20</volume>, <fpage>286</fpage>&#x2013;<lpage>293</lpage>. doi: <pub-id pub-id-type="doi">10.1093/hmg/ddq463</pub-id></citation></ref>
<ref id="ref120"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname> <given-names>S.</given-names></name> <name><surname>Oiwa</surname> <given-names>K.</given-names></name> <name><surname>Murata</surname> <given-names>Y.</given-names></name> <name><surname>Komine</surname> <given-names>O.</given-names></name> <name><surname>Sobue</surname> <given-names>A.</given-names></name> <name><surname>Endo</surname> <given-names>F.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>ALS-linked TDP-43(M337V) knock-in mice exhibit splicing deregulation without neurodegeneration</article-title>. <source>Mol. Brain</source> <volume>13</volume>:<fpage>8</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13041-020-0550-4</pub-id></citation></ref>
<ref id="ref121"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>White</surname> <given-names>M. A.</given-names></name> <name><surname>Kim</surname> <given-names>E.</given-names></name> <name><surname>Duffy</surname> <given-names>A.</given-names></name> <name><surname>Adalbert</surname> <given-names>R.</given-names></name> <name><surname>Phillips</surname> <given-names>B. U.</given-names></name> <name><surname>Peters</surname> <given-names>O. M.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>TDP-43 gains function due to perturbed autoregulation in a Tardbp knock-in mouse model of ALS-FTD</article-title>. <source>Nat. Neurosci.</source> <volume>21</volume>, <fpage>552</fpage>&#x2013;<lpage>563</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41593-018-0113-5</pub-id></citation></ref>
<ref id="ref122"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname> <given-names>S. R.</given-names></name> <name><surname>Stuart</surname> <given-names>G. J.</given-names></name></person-group> (<year>1999</year>). <article-title>Mechanisms and consequences of action potential burst firing in rat neocortical pyramidal neurons</article-title>. <source>J. Physiol.</source> <volume>521</volume>, <fpage>467</fpage>&#x2013;<lpage>482</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1469-7793.1999.00467.x</pub-id></citation></ref>
<ref id="ref123"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wolozin</surname> <given-names>B.</given-names></name> <name><surname>Ivanov</surname> <given-names>P.</given-names></name></person-group> (<year>2019</year>). <article-title>Stress granules and neurodegeneration</article-title>. <source>Nat. Rev. Neurosci.</source> <volume>20</volume>, <fpage>649</fpage>&#x2013;<lpage>666</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41583-019-0222-5</pub-id></citation></ref>
<ref id="ref124"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname> <given-names>C. E.</given-names></name> <name><surname>Jin</surname> <given-names>L. W.</given-names></name> <name><surname>Chu</surname> <given-names>Y. P.</given-names></name> <name><surname>Wei</surname> <given-names>W. Y.</given-names></name> <name><surname>Ho</surname> <given-names>P. C.</given-names></name> <name><surname>Tsai</surname> <given-names>K. J.</given-names></name></person-group> (<year>2021</year>). <article-title>TDP-43 proteinopathy impairs mRNP granule mediated postsynaptic translation and mRNA metabolism</article-title>. <source>Theranostics</source> <volume>11</volume>, <fpage>330</fpage>&#x2013;<lpage>345</lpage>. doi: <pub-id pub-id-type="doi">10.7150/thno.51004</pub-id></citation></ref>
</ref-list>
</back>
</article>